A. Agrawal, A. J. Budney, and M. T. Lynskey, The co-occurring use and misuse of cannabis and tobacco: a review, Addict. Abingdon Engl, vol.107, pp.1221-1233, 2012.

F. J. Ascaso, N. Cruz, P. J. Modrego, R. Lopez-anton, J. Santabárbara et al., Retinal alterations in mild cognitive impairment and Alzheimer's disease: an optical coherence tomography study, J. Neurol, vol.261, pp.1522-1530, 2014.

N. Auclair, S. Otani, P. Soubrie, and F. Crepel, Cannabinoids modulate synaptic strength and plasticity at glutamatergic synapses of rat prefrontal cortex pyramidal neurons, J. Neurophysiol, vol.83, pp.3287-3293, 2000.

,

M. Bach, M. G. Brigell, M. Hawlina, G. E. Holder, M. A. Johnson et al., ISCEV standard for clinical pattern electroretinography (PERG): 2012 update, Doc. Ophthalmol. Adv. Ophthalmol, vol.126, pp.1-7, 2013.

A. Baghaie, Z. Yu, and R. M. Souza, State-of-the-art in retinal optical coherence tomography image analysis. Quant, Imaging Med. Surg, vol.5, pp.603-617, 2015.

A. Baghaie, Z. Yu, and R. M. Souza, State-of-the-art in retinal optical coherence tomography image analysis. Quant, Imaging Med. Surg, vol.5, pp.603-617, 2015.

Z. Balogh, G. Benedek, and S. Kéri, Retinal dysfunctions in schizophrenia, Prog. Neuropsychopharmacol. Biol. Psychiatry, vol.32, pp.297-300, 2008.

,

D. Baylor, How photons start vision, Proc. Natl. Acad. Sci. U. S. A, vol.93, pp.560-565, 1996.

J. Beaulieu and R. R. Gainetdinov, The physiology, signaling, and pharmacology of dopamine receptors, Pharmacol. Rev, vol.63, pp.182-217, 2011.

F. Bernardin, R. Schwan, L. Lalanne, F. Ligier, K. Angioi-duprez et al., The role of the retina in visual hallucinations: A review of the literature and implications for psychosis, Neuropsychologia, vol.99, pp.128-138, 2017.
URL : https://hal.archives-ouvertes.fr/hal-02337395

I. Bodis-wollner, M. S. Marx, S. Mitra, P. Bobak, L. Mylin et al., Visual dysfunction in Parkinson's disease. Loss in spatiotemporal contrast sensitivity, Brain J. Neurol, vol.110, pp.1675-1698, 1987.

I. Bodis-wollner and M. D. Yahr, Measurements of visual evoked potentials in Parkinson's disease, Brain J. Neurol, vol.101, pp.661-671, 1978.

D. O. Borroto-escuela, J. Pintsuk, T. Schäfer, K. Friedland, L. Ferraro et al., Multiple D2 heteroreceptor complexes: new targets for treatment of schizophrenia, Ther. Adv. Psychopharmacol, vol.6, pp.77-94, 2016.

M. G. Bossong and R. J. Niesink, Adolescent brain maturation, the endogenous cannabinoid system and the neurobiology of cannabis-induced schizophrenia, 2010.

, Prog. Neurobiol, vol.92, pp.370-385

B. Wässle and H. , Parallel processing in the mammalian retina: the Proctor Lecture, Anomalies fonctionnelles rétiniennes dans les troubles neuropsychiatriques et leurs liens avec les dysfonctionnements cérébraux Habilitation à diriger les recherches-Thomas Schwitzer Boycott, vol.40, pp.1313-1327, 1999.

C. Brandon and D. M. Lam, L-glutamic acid: a neurotransmitter candidate for cone photoreceptors in human and rat retinas, Proc. Natl. Acad. Sci. U. S. A, vol.80, pp.5117-5121, 1983.

D. Brites and A. Fernandes, Neuroinflammation and Depression: Microglia Activation, Extracellular Microvesicles and microRNA Dysregulation, Front. Cell. Neurosci, vol.9, 2015.

S. J. Broyd, H. H. Van-hell, C. Beale, M. Yücel, and N. Solowij, Acute and Chronic Effects of Cannabinoids on Human Cognition-A Systematic Review, Biol. Psychiatry, vol.79, pp.557-567, 2016.

E. Bubl, M. Dörr, A. Philipsen, D. Ebert, M. Bach et al., Retinal contrast transfer functions in adults with and without ADHD, PloS One, vol.8, 2013.

E. Bubl, D. Ebert, E. Kern, L. T. Van-elst, and M. Bach, Effect of antidepressive therapy on retinal contrast processing in depressive disorder, Br. J. Psychiatry J. Ment. Sci, vol.201, pp.151-158, 2012.

E. Bubl, E. Kern, D. Ebert, M. Bach, and L. Tebartz-van-elst, Seeing gray when feeling blue? Depression can be measured in the eye of the diseased, Biol. Psychiatry, vol.68, pp.205-208, 2010.

E. Bubl, E. Kern, D. Ebert, A. Riedel, L. Tebartz-van-elst et al., Retinal dysfunction of contrast processing in major depression also apparent in cortical activity, Eur. Arch. Psychiatry Clin. Neurosci, 2015.

R. R. Buggage, C. C. Chan, and R. B. Nussenblatt, Ocular manifestations of central nervous system lymphoma, Curr. Opin. Oncol, vol.13, pp.137-142, 2001.

R. N. Caballero-florán, I. Conde-rojas, A. Oviedo-chávez, H. Cortes-calleja, L. F. Lopez-santiago et al., Cannabinoid-induced depression of synaptic transmission is switched to stimulation when dopaminergic tone is increased in the globus pallidus of the rodent, Neuropharmacology, vol.110, pp.407-418, 2016.

,

G. G. Celesia, D. Kaufman, and S. B. Cone, Simultaneous recording of pattern electroretinography and visual evoked potentials in multiple sclerosis. A method to separate demyelination from axonal damage to the optic nerve, Arch. Neurol, vol.43, pp.1247-1252, 1986.

J. Chen, I. Matias, T. Dinh, T. Lu, S. Venezia et al., Finding of endocannabinoids in human eye tissues: implications for glaucoma, Biochem. Biophys. Res. Commun, vol.330, pp.1062-1067, 2005.

C. Y. Cheung, C. Chen, and T. Y. Wong, Ocular Fundus Photography as a Tool to Study Stroke and Dementia, Semin. Neurol, vol.35, pp.481-490, 2015.

,

C. Y. Cheung, .. Ikram, M. K. Chen, C. Wong, and T. Y. , Imaging retina to study dementia and stroke, Prog. Retin. Eye Res, vol.57, pp.89-107, 2017.

,

C. Y. Cheung, .. Ong, Y. Ikram, M. K. Chen, C. Wong et al., Retinal microvasculature in Alzheimer's disease, J. Alzheimers Dis. JAD, vol.42, pp.339-352, 2014.

, Anomalies fonctionnelles rétiniennes dans les troubles neuropsychiatriques et leurs liens avec les dysfonctionnements cérébraux Habilitation à diriger les recherches-Thomas Schwitzer

P. A. Constable, M. Bach, L. J. Frishman, B. G. Jeffrey, and A. G. Robson, International Society for Clinical Electrophysiology of Vision, 2017. ISCEV Standard for clinical electro-oculography (2017 update), Doc. Ophthalmol. Adv. Ophthalmol, vol.134, pp.1-9

A. Cronin-golomb, J. F. Rizzo, S. Corkin, and J. H. Growdon, Visual Function in Alzheimer's Disease and Normal Aginga, Ann. N. Y. Acad. Sci, vol.640, pp.28-35, 1991.

R. W. Crow, L. B. Levin, L. Labree, R. Rubin, and S. E. Feldon, Sweep Visual Evoked Potential Evaluation of Contrast Sensitivity in Alzheimer's Dementia, Invest. Ophthalmol. Vis. Sci, vol.44, pp.875-878, 2003.

S. Davanger, O. P. Ottersen, and J. Storm-mathisen, Glutamate, GABA, and glycine in the human retina: an immunocytochemical investigation, J. Comp. Neurol, vol.311, pp.483-494, 1991.

C. F. De-souza, M. L. Acosta, P. J. Polkinghorne, C. N. Mcghee, and M. Kalloniatis, Amino acid immunoreactivity in normal human retina and after brachytherapy, Clin. Exp. Optom. J. Aust. Optom. Assoc, vol.96, pp.504-507, 2013.

L. Degenhardt, W. Chiu, N. Sampson, R. C. Kessler, J. C. Anthony et al., Toward a global view of alcohol, tobacco, cannabis, and cocaine use: findings from the WHO World Mental Health Surveys, PLoS Med, vol.5, 2008.

J. E. Dowling and B. Ehinger, The interplexiform cell system. I. Synapses of the dopaminergic neurons of the goldfish retina, Proc. R. Soc. Lond. Ser. B Contain. Pap. Biol. Character R. Soc. G. B, vol.201, pp.7-26, 1978.

A. A. El-shazly, -. Farweez, Y. A. Elzankalony, Y. A. Elewa, L. S. Farweez et al., EFFECT OF SMOKING ON MACULAR FUNCTION AND STRUCTURE IN ACTIVE SMOKERS VERSUS PASSIVE SMOKERS. Retina Phila. Pa, vol.38, pp.1031-1040, 2018.

J. Fam, A. J. Rush, B. Haaland, S. Barbier, and C. Luu, Visual contrast sensitivity in major depressive disorder, J. Psychosom. Res, vol.75, pp.83-86, 2013.

E. V. Famiglietti and H. Kolb, Structural basis for ON-and OFF-center responses in retinal ganglion cells, Science, vol.194, pp.193-195, 1976.

S. Fan and S. Yazulla, Retrograde endocannabinoid inhibition of goldfish retinal cones is mediated by 2-arachidonoyl glycerol, Vis. Neurosci, vol.24, pp.257-267, 2007.

S. Fan and S. Yazulla, Reciprocal inhibition of voltage-gated potassium currents (I K(V)) by activation of cannabinoid CB1 and dopamine D1 receptors in ON bipolar cells of goldfish retina, Vis. Neurosci, vol.22, pp.55-63, 2005.

S. Fan and S. Yazulla, Inhibitory interaction of cannabinoid CB1 receptor and dopamine D2 receptor agonists on voltage-gated currents of goldfish cones, Vis. Neurosci, vol.21, pp.69-77, 2004.

, Anomalies fonctionnelles rétiniennes dans les troubles neuropsychiatriques et leurs liens avec les dysfonctionnements cérébraux Habilitation à diriger les recherches-Thomas Schwitzer depression: Tagging the developmental roots of major psychiatric disorders, Prog. Neuropsychopharmacol. Biol. Psychiatry, vol.75, pp.10-15

,

M. Hébert, . Vaegan, and P. Lachapelle, Reproducibility of ERG responses obtained with the DTL electrode, Vision Res, vol.39, pp.1069-1070, 1999.

W. Ho, Y. Leung, A. W. Tsang, .. So, K. Chiu et al., Review: tauopathy in the retina and optic nerve: does it shadow pathological changes in the brain?, Mol. Vis, vol.18, pp.2700-2710, 2012.

G. E. Holder, Pattern electroretinography (PERG) and an integrated approach to visual pathway diagnosis, Prog. Retin. Eye Res, vol.20, pp.531-561, 2001.

G. E. Holder, G. G. Celesia, Y. Miyake, S. Tobimatsu, and R. G. Weleber, International Federation of Clinical Neurophysiology: recommendations for visual system testing, Clin. Neurophysiol. Off. J. Int. Fed. Clin. Neurophysiol, vol.121, pp.1393-1409, 2010.

G. E. Holder, R. P. Gale, J. F. Acheson, and A. G. Robson, Electrodiagnostic assessment in optic nerve disease, Curr. Opin. Neurol, vol.22, pp.3-10, 2009.

L. E. Hong, M. Tagamets, M. Avila, I. Wonodi, H. Holcomb et al., Specific motion processing pathway deficit during eye tracking in schizophrenia: a performance-matched functional magnetic resonance imaging study, Biol. Psychiatry, vol.57, pp.726-732, 2005.

,

D. C. Hood, M. Bach, M. Brigell, D. Keating, M. Kondo et al., International Society For Clinical Electrophysiology of Vision, 2012. ISCEV standard for clinical multifocal electroretinography (mfERG, Doc. Ophthalmol. Adv. Ophthalmol, vol.124, pp.1-13

M. Hoon, H. Okawa, L. Della-santina, and R. O. Wong, Functional architecture of the retina: Development and disease, Prog. Retin. Eye Res, vol.42, pp.44-84, 2014.

T. Huang and C. Lin, Advances in biomarkers of major depressive disorder, Adv. Clin. Chem, vol.68, pp.177-204, 2015.

V. L. Ives-deliperi, F. Howells, D. J. Stein, E. M. Meintjes, and N. Horn, The effects of mindfulness-based cognitive therapy in patients with bipolar disorder: a controlled functional MRI investigation, J. Affect. Disord, vol.150, pp.1152-1157, 2013.

K. Januschowski, S. Müller, C. Krupp, M. S. Spitzer, J. Hurst et al., Glutamate and hypoxia as a stress model for the isolated perfused vertebrate retina, J. Vis. Exp. JoVE, 2015.

G. M. Khandaker, L. Cousins, J. Deakin, B. R. Lennox, R. Yolken et al., Inflammation and immunity in schizophrenia: implications for pathophysiology and treatment, Lancet Psychiatry, vol.2, pp.122-131, 2015.

G. M. Khandaker and R. Dantzer, Is there a role for immune-to-brain communication in schizophrenia?, Psychopharmacology (Berl.), vol.233, pp.1559-1573, 2016.

, Anomalies fonctionnelles rétiniennes dans les troubles neuropsychiatriques et leurs liens avec les dysfonctionnements cérébraux Habilitation à diriger les recherches-Thomas Schwitzer

D. J. Kim and S. A. Thayer, Activation of CB1 cannabinoid receptors inhibits neurotransmitter release from identified synaptic sites in rat hippocampal cultures, Brain Res, vol.852, pp.398-405, 2000.

H. K. Kim, P. V. Nunes, K. C. Oliveira, L. T. Young, and B. Lafer, Neuropathological relationship between major depression and dementia: A hypothetical model and review, Prog. Neuropsychopharmacol. Biol. Psychiatry, vol.67, pp.51-57, 2016.

M. Koronyo-hamaoui, Y. Koronyo, A. V. Ljubimov, C. A. Miller, M. K. Ko et al., Identification of amyloid plaques in retinas from Alzheimer's patients and noninvasive in vivo optical imaging of retinal plaques in a mouse model, NeuroImage, vol.54, issue.1, pp.204-217, 2011.

P. Koulen, Clustering of neurotransmitter receptors in the mammalian retina, J. Membr. Biol, vol.171, pp.97-105, 1999.

K. Krasodomska, W. Lubi?ski, A. Potemkowski, and K. Honczarenko, Pattern electroretinogram (PERG) and pattern visual evoked potential (PVEP) in the early stages of Alzheimer's disease, Doc. Ophthalmol. Adv. Ophthalmol, vol.121, pp.111-121, 2010.

L. Morgia, C. Ross-cisneros, F. N. Koronyo, Y. Hannibal, J. Gallassi et al., Melanopsin retinal ganglion cell loss in Alzheimer disease, Ann. Neurol, vol.79, pp.90-109, 2016.

M. R. Lalonde, C. A. Jollimore, K. Stevens, S. Barnes, and M. E. Kelly, Cannabinoid receptor-mediated inhibition of calcium signaling in rat retinal ganglion cells, Mol. Vis, vol.12, pp.1160-1166, 2006.

T. Langheinrich, L. Tebartz-van-elst, W. A. Lagrèze, M. Bach, C. H. Lücking et al., Visual contrast response functions in Parkinson's disease: evidence from electroretinograms, visually evoked potentials and psychophysics, Clin. Neurophysiol. Off. J. Int. Fed. Clin. Neurophysiol, vol.111, pp.66-74, 2000.

V. Laprevote, T. Schwitzer, A. Giersch, and R. Schwan, Flash electroretinogram and addictive disorders, Prog. Neuropsychopharmacol. Biol. Psychiatry, vol.56, 2015.

J. Lavoie, M. Hébert, and J. Beaulieu, Looking beyond the role of glycogen synthase kinase-3 genetic expression on electroretinogram response: what about lithium?, Biol. Psychiatry, vol.77, pp.15-17, 2015.

,

J. Lavoie, P. Illiano, T. D. Sotnikova, R. R. Gainetdinov, J. Beaulieu et al., The electroretinogram as a biomarker of central dopamine and serotonin: potential relevance to psychiatric disorders, Biol. Psychiatry, vol.75, pp.479-486, 2014.

J. Lavoie, P. Illiano, T. D. Sotnikova, R. R. Gainetdinov, J. Beaulieu et al., The electroretinogram as a biomarker of central dopamine and serotonin: potential relevance to psychiatric disorders, Biol. Psychiatry, vol.75, pp.479-486, 2014.

J. Lavoie, M. Maziade, and M. Hébert, The brain through the retina: The flash electroretinogram as a tool to investigate psychiatric disorders, 2014.

, Anomalies fonctionnelles rétiniennes dans les troubles neuropsychiatriques et leurs liens avec les dysfonctionnements cérébraux Habilitation à diriger les recherches-Thomas Schwitzer update), vol.130, pp.1-12

,

R. Mechoulam and L. Hanus, A historical overview of chemical research on cannabinoids, Chem. Phys. Lipids, vol.108, pp.1-13, 2000.

R. Mechoulam and L. A. Parker, The Endocannabinoid System and the Brain, Annu. Rev. Psychol, vol.64, pp.21-47, 2013.

R. Mechoulam, M. Peters, E. Murillo-rodriguez, and L. O. Hanus, Cannabidiol--recent advances, Chem. Biodivers, vol.4, pp.1678-1692, 2007.

,

M. H. Meier, A. Caspi, A. Ambler, H. Harrington, R. Houts et al., Persistent cannabis users show neuropsychological decline from childhood to midlife, Proc. Natl. Acad. Sci, vol.109, pp.2657-2664, 2012.

T. P. Middleton and D. A. Protti, Cannabinoids modulate spontaneous synaptic activity in retinal ganglion cells, Vis. Neurosci, vol.28, pp.393-402, 2011.

J. J. Miguel-hidalgo, Molecular Neuropathology of Astrocytes and Oligodendrocytes in Alcohol Use Disorders, Front. Mol. Neurosci, vol.11, 2018.

M. M. Moschos, I. Markopoulos, I. Chatziralli, A. Rouvas, S. G. Papageorgiou et al., Structural and functional impairment of the retina and optic nerve in Alzheimer's disease, Curr. Alzheimer Res, vol.9, pp.782-788, 2012.

J. Nguyen-legros, A. Simon, I. Caillé, and B. Bloch, Immunocytochemical localization of dopamine D1 receptors in the retina of mammals, Vis. Neurosci, vol.14, pp.545-551, 1997.

J. V. Odom, M. Bach, M. Brigell, G. E. Holder, D. L. Mcculloch et al., ISCEV standard for clinical visual evoked potentials (2009 update), Doc. Ophthalmol. Adv. Ophthalmol, vol.120, pp.111-119, 2010.

,

C. A. Opere, W. D. Zheng, M. Zhao, J. S. Lee, K. H. Kulkarni et al., Inhibition of potassium-and ischemia-evoked [3H] D-aspartate release from isolated bovine retina by cannabinoids, Curr. Eye Res, vol.31, pp.645-653, 2006.

A. M. Palmowski-wolfe, M. T. Perez, S. Behnke, G. Fuss, M. Martziniak et al., Influence of dopamine deficiency in early Parkinson's disease on the slow stimulation multifocal-ERG, Doc. Ophthalmol. Adv. Ophthalmol, vol.112, pp.209-215, 2006.

V. Parisi, R. Restuccia, F. Fattapposta, C. Mina, M. G. Bucci et al., Morphological and functional retinal impairment in Alzheimer's disease patients, Clin. Neurophysiol. Off. J. Int. Fed. Clin. Neurophysiol, vol.112, pp.1860-1867, 2001.

R. Parthasarathy, K. M. Chow, Z. Derafshi, M. P. Fautsch, J. R. Hetling et al., Reduction of amyloid-beta levels in mouse eye tissues by intra-vitreally delivered neprilysin, Exp. Eye Res, vol.138, pp.134-144, 2015.

O. Pasternak, M. Kubicki, and M. E. Shenton, In vivo imaging of neuroinflammation in schizophrenia, Schizophr. Res, 2015.

N. Patton, T. Aslam, T. Macgillivray, A. Pattie, I. J. Deary et al., Retinal vascular image analysis as a potential screening tool for cerebrovascular disease: a rationale based on homology between cerebral and retinal microvasculatures, J. Anat, vol.206, pp.319-348, 2005.

N. Patton, T. M. Aslam, T. Macgillivray, I. J. Deary, B. Dhillon et al., Retinal image analysis: concepts, applications and potential, Prog. Retin. Eye Res, vol.25, pp.99-127, 2006.

A. Peppe, P. Stanzione, F. Pierelli, D. De-angelis, M. Pierantozzi et al., Visual alterations in de novo Parkinson's disease: pattern electroretinogram latencies are more delayed and more reversible by levodopa than are visual evoked potentials, Neurology, vol.45, pp.1144-1148, 1995.

R. G. Pertwee, A. C. Howlett, M. E. Abood, S. P. Alexander, V. Di-marzo et al., International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB? and CB?, Pharmacol. Rev, vol.62, pp.588-631, 2010.

E. Popova, Role of dopamine in distal retina, J. Comp. Physiol. A Neuroethol. Sens. Neural. Behav. Physiol, vol.200, pp.333-358, 2014.

E. Popova, Ionotropic GABA Receptors and Distal Retinal ON and OFF Responses, Scientifica, 2014.

A. Porcella, C. Maxia, G. L. Gessa, and L. Pani, The human eye expresses high levels of CB1 cannabinoid receptor mRNA and protein, Eur. J. Neurosci, vol.12, pp.1123-1127, 2000.

N. V. Rangaswamy, L. J. Frishman, E. U. Dorotheo, J. S. Schiffman, H. M. Bahrani et al., Photopic ERGs in patients with optic neuropathies: comparison with primate ERGs after pharmacologic blockade of inner retina, Invest. Ophthalmol. Vis. Sci, vol.45, pp.3827-3837, 2004.

R. A. Reis, A. L. Ventura, R. C. Kubrusly, M. C. De-mello, and F. G. De-mello, Dopaminergic signaling in the developing retina, Brain Res. Rev, vol.54, pp.181-188, 2007.

D. Robbe, G. Alonso, F. Duchamp, J. Bockaert, and O. J. Manzoni, Localization and mechanisms of action of cannabinoid receptors at the glutamatergic synapses of the mouse nucleus accumbens, J. Neurosci. Off. J. Soc. Neurosci, vol.21, pp.109-116, 2001.

S. G. Rosolen, F. Rigaudière, J. Legargasson, C. Chalier, M. Rufiange et al., Comparing the photopic ERG i-wave in different species, Vet. Ophthalmol, vol.7, pp.189-192, 2004.

A. Roy, M. Roy, J. Berman, and B. Gonzalez, Blue cone electroretinogram amplitudes are related to dopamine function in cocaine-dependent patients, Psychiatry Res, vol.117, pp.191-195, 2003.

, Anomalies fonctionnelles rétiniennes dans les troubles neuropsychiatriques et leurs liens avec les dysfonctionnements cérébraux Habilitation à diriger les recherches-Thomas Schwitzer

M. Roy, A. Roy, D. Smelson, S. Brown, and L. Weinberger, Reduced blue cone electroretinogram in withdrawn cocaine dependent patients: a replication, Biol. Psychiatry, vol.42, pp.631-633, 1997.

M. Roy, A. Roy, J. Williams, L. Weinberger, and D. Smelson, Reduced blue cone electroretinogram in cocaine-withdrawn patients, Arch. Gen. Psychiatry, vol.54, pp.153-156, 1997.

G. Sanacora, G. F. Mason, D. L. Rothman, K. L. Behar, F. Hyder et al., Reduced cortical gammaaminobutyric acid levels in depressed patients determined by proton magnetic resonance spectroscopy, Arch. Gen. Psychiatry, vol.56, pp.1043-1047, 1999.

G. Sanacora, G. F. Mason, D. L. Rothman, F. Hyder, J. J. Ciarcia et al., Increased cortical GABA concentrations in depressed patients receiving ECT, Am. J. Psychiatry, vol.160, pp.577-579, 2003.

E. Schlicker, J. Timm, and M. Göthert, Cannabinoid receptor-mediated inhibition of dopamine release in the retina, Naunyn. Schmiedebergs Arch. Pharmacol, vol.354, pp.791-795, 1996.

T. Schwitzer, J. Lavoie, A. Giersch, R. Schwan, and V. Laprevote, The emerging field of retinal electrophysiological measurements in psychiatric research: A review of the findings and the perspectives in major depressive disorder, J. Psychiatr. Res, vol.70, pp.113-120, 2015.

,

T. Schwitzer, M. P. Robert, A. Giersch, K. Angioi-duprez, I. Ingster-moati et al., Transient Retinal Dysfunctions after Acute Cannabis Use, Eur. Addict. Res, vol.22, pp.287-291, 2016.

T. Schwitzer, R. Schwan, E. Albuisson, A. Giersch, L. Lalanne et al., Association Between Regular Cannabis Use and Ganglion Cell Dysfunction, JAMA Ophthalmol, vol.135, pp.54-60, 2017.

,

T. Schwitzer, R. Schwan, K. Angioi-duprez, A. Giersch, L. Lalanne et al., Delayed bipolar and ganglion cells neuroretinal processing in regular cannabis users: The retina as a relevant site to investigate brain synaptic transmission dysfunctions, J. Psychiatr. Res, vol.103, pp.75-82, 2018.

T. Schwitzer, R. Schwan, K. Angioi-duprez, A. Giersch, and V. Laprevote, The Endocannabinoid System in the Retina: From Physiology to Practical and Therapeutic Applications, Neural Plast, 2016.

T. Schwitzer, R. Schwan, K. Angioi-duprez, I. Ingster-moati, L. Lalanne et al., The cannabinoid system and visual processing: a review on experimental findings and clinical presumptions, Eur. Neuropsychopharmacol. J. Eur. Coll. Neuropsychopharmacol, vol.25, pp.100-112, 2015.

T. Schwitzer, R. Schwan, F. Bernardin, C. Jeantet, K. Angioi-duprez et al., Commentary: Anatomical constitution of sense organs as a marker of mental disorders, Front. Behav. Neurosci, vol.10, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01586834

T. Schwitzer, R. Schwan, E. Bubl, L. Lalanne, K. Angioi-duprez et al., Looking into the brain through the retinal ganglion cells in psychiatric disorders: A review of evidences, Prog. Neuropsychopharmacol. Biol. Psychiatry, 2017.

J. Seggie, H. Macmillan, L. Griffith, H. S. Shannon, J. Martin et al., Retinal pigment epithelium response and the use of the EOG and Arden Ratio in depression, Psychiatry Res, vol.36, pp.175-185, 1991.

R. C. Sergott, E. Frohman, R. Glanzman, and A. Al-sabbagh, The role of optical coherence tomography in multiple sclerosis: expert panel consensus, J. Neurol. Sci, vol.263, pp.3-14, 2007.

,

J. W. Shum, K. Liu, and K. So, The progress in optic nerve regeneration, where are we?, Neural Regen. Res, vol.11, pp.32-36, 2016.

S. M. Silverstein and R. Rosen, Schizophrenia and the eye, Schizophr. Res. Cogn, vol.2, pp.46-55, 2015.

W. D. Stamer, S. F. Golightly, Y. Hosohata, E. P. Ryan, A. C. Porter et al., Cannabinoid CB(1) receptor expression, activation and detection of endogenous ligand in trabecular meshwork and ciliary process tissues, Eur. J. Pharmacol, vol.431, pp.277-286, 2001.

A. Straiker, N. Stella, D. Piomelli, K. Mackie, H. J. Karten et al., Cannabinoid CB1 receptors and ligands in vertebrate retina: localization and function of an endogenous signaling system, Proc. Natl. Acad. Sci. U. S. A, vol.96, pp.14565-14570, 1999.

A. Straiker and J. M. Sullivan, Cannabinoid receptor activation differentially modulates ion channels in photoreceptors of the tiger salamander, J. Neurophysiol, vol.89, pp.2647-2654, 2003.

A. J. Straiker, G. Maguire, K. Mackie, and J. Lindsey, Localization of cannabinoid CB1 receptors in the human anterior eye and retina, Invest. Ophthalmol. Vis. Sci, vol.40, pp.2442-2448, 1999.

M. J. Stuart, G. Singhal, and B. T. Baune, Systematic Review of the Neurobiological Relevance of Chemokines to Psychiatric Disorders, Front. Cell. Neurosci, vol.9, 2015.

B. Szabo, L. Dörner, C. Pfreundtner, W. Nörenberg, and K. Starke, Inhibition of GABAergic inhibitory postsynaptic currents by cannabinoids in rat corpus striatum, Neuroscience, vol.85, pp.395-403, 1998.

B. Szabo, S. Siemes, and I. Wallmichrath, Inhibition of GABAergic neurotransmission in the ventral tegmental area by cannabinoids, Eur. J. Neurosci, vol.15, pp.2057-2061, 2002.

S. B. Varghese, J. C. Reid, E. E. Hartmann, and K. T. Keyser, The effects of nicotine on the human electroretinogram, Invest. Ophthalmol. Vis. Sci, vol.52, pp.9445-9451, 2011.

N. D. Volkow, R. D. Baler, W. M. Compton, and S. R. Weiss, Adverse health effects of marijuana use, N. Engl. J. Med, vol.370, pp.2219-2227, 2014.

L. Wachtmeister, Oscillatory potentials in the retina: what do they reveal, Prog. Retin. Eye Res, vol.17, pp.485-521, 1998.

J. Wang, Y. Wu, S. Heegaard, and M. Kolko, Cyclooxygenase-2 expression in the normal human eye and its expression pattern in selected eye tumours, 2011.

, Anomalies fonctionnelles rétiniennes dans les troubles neuropsychiatriques et leurs liens avec les dysfonctionnements

D. L. Boudard, N. Tanimoto, G. Huber, S. C. Beck, M. W. Seeliger et al., Cone loss is delayed relative to rod loss during induced retinal degeneration in the diurnal cone-rich rodent Arvicanthis ansorgei, Neuroscience, vol.169, pp.1815-1830, 2010.

D. S. Charney and H. K. Manji, Life stress, genes, and depression: multiple pathways lead to increased risk and new opportunities for intervention, Sci. STKE Signal Transduct. Knowl. Environ, p.5, 2004.

L. K. Fonken, E. Kitsmiller, L. Smale, and R. J. Nelson, Dim nighttime light impairs cognition and provokes depressive-like responses in a diurnal rodent, J. Biol. Rhythms, vol.27, pp.319-327, 2012.

L. K. Fonken and R. J. Nelson, Dim light at night increases depressive-like responses in male C3H/HeNHsd mice, Behav. Brain Res, vol.243, pp.74-78, 2013.

M. J. Gastinger, N. Tian, T. Horvath, and D. W. Marshak, Retinopetal axons in mammals: emphasis on histamine and serotonin, Curr. Eye Res, vol.31, pp.655-667, 2006.

C. Gianesini, D. Clesse, G. Tosini, D. Hicks, and V. Laurent, Unique Regulation of the Melatonin Synthetic Pathway in the Retina of Diurnal Female Arvicanthis ansorgei (Rodentia), Endocrinology, vol.156, pp.3292-3308, 2015.

M. Hamon and P. Blier, Monoamine neurocircuitry in depression and strategies for new treatments, Prog. Neuropsychopharmacol. Biol. Psychiatry, vol.45, pp.54-63, 2013.

J. Hubbard, E. Ruppert, L. Calvel, L. Robin-choteau, C. Gropp et al., Arvicanthis ansorgei, a Novel Model for the Study of Sleep and Waking in Diurnal Rodents, Sleep, vol.38, pp.979-988, 2015.

R. W. Lam, A. J. Levitt, R. D. Levitan, E. E. Michalak, A. H. Cheung et al., Efficacy of Bright Light Treatment, Fluoxetine, and the Combination in Patients With Nonseasonal Major Depressive Disorder: A Randomized Clinical Trial, JAMA Psychiatry, vol.73, pp.56-63, 2016.

J. Lavoie, P. Illiano, T. D. Sotnikova, R. R. Gainetdinov, J. Beaulieu et al., The electroretinogram as a biomarker of central dopamine and serotonin: potential relevance to psychiatric disorders, Biol. Psychiatry, vol.75, pp.479-486, 2014.

V. Porciatti, The mouse pattern electroretinogram, Doc. Ophthalmol. Adv. Ophthalmol, vol.115, pp.145-153, 2007.

T. Schwitzer, J. Lavoie, A. Giersch, R. Schwan, and V. Laprevote, The emerging field of retinal electrophysiological measurements in psychiatric research: A review of the findings and the perspectives in major depressive disorder, J. Psychiatr. Res, vol.70, pp.113-120, 2015.

T. Schwitzer, R. Schwan, F. Bernardin, C. Jeantet, K. Angioi-duprez et al., Commentary: Anatomical constitution of sense organs as a marker of mental disorders, Front. Behav. Neurosci, vol.10, p.56, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01586834

R. Adams, A. J. Brown, B. Haegerstrom-portnoy, G. Flom, M. C. Jones et al., Marijuana, alcohol, and combined drug effects on the time course of glare recovery, Psychopharmacology, vol.56, pp.81-86, 1978.

J. P. Aggleton, Looking beyond the hippocampus: old and new neurological targets for understanding memory disorders, Proc. Biol. Sci, vol.281, pp.1-9, 2014.

A. Agrawal, A. J. Budney, and M. T. Lynskey, The co-occurring use and misuse of cannabis and tobacco: a review, Addiction, vol.107, pp.1221-1233, 2012.

J. C. Ashton, D. Friberg, C. L. Darlington, and P. F. Smith, Expression of the cannabinoid CB2 receptor in the rat cerebellum: an immunohistochemical study, Neurosci. Lett, vol.396, pp.113-116, 2006.

E. V. Berdyshev, Cannabinoid receptors and the regulation of immune response, Chem. Phys. Lipids, vol.108, pp.169-190, 2000.

T. Bisogno, I. Delton-vandenbroucke, A. Milone, M. Lagarde, and V. Di-marzo, Biosynthesis and inactivation of Narachidonoylethanolamine (anandamide) and N-docosahexaenoylethanolamine in bovine retina, Arch. Biochem. Biophys, vol.370, pp.300-307, 1999.

K. B. Böcker, J. Gerritsen, C. C. Hunault, M. Kruidenier, T. T. Mensinga et al., Cannabis with high ?9-THC contents affects perception and visual selective attention acutely: an event-related potential study, Pharmacol. Biochem. Behav, vol.96, pp.67-74, 2010.

K. I. Bolla, K. Brown, D. Eldreth, K. Tate, and J. L. Cadet, Dose-related neurocognitive effects of marijuana use, Neurology, vol.59, pp.1337-1343, 2002.

M. G. Bossong and R. J. Niesink, Adolescent brain maturation, the endogenous cannabinoid system and the neurobiology of cannabis-induced schizophrenia, Prog. Neurobiol, vol.92, pp.370-385, 2010.

J. Bouskila, M. W. Burke, N. Zabouri, C. Casanova, M. Ptito et al., Expression and localization of the cannabinoid receptor type 1 and the enzyme fatty acid amide hydrolase in the retina of vervet monkeys, Neuroscience, vol.202, pp.117-130, 2012.

J. Bouskila, P. Javadi, C. Casanova, M. Ptito, and J. Bouchard, Müller cells express the cannabinoid CB2 receptor in the vervet monkey retina, J. Comp. Neurol, vol.521, pp.2399-2415, 2013.

L. N. Brown, L. M. Metz, and R. S. Sainsbury, Sensory temporal thresholds and interhemispheric transfer times in multiple sclerosis: a preliminary study of a new outcome measure, J. Clin. Exp. Neuropsychol, vol.25, pp.783-792, 2003.

N. E. Buckley, S. Hansson, G. Harta, and E. Mezey, Expression of the CB1 and CB2 receptor messenger RNAs during embryonic development in the rat, Neuroscience, vol.82, pp.1131-1149, 1998.

A. S. Carlin, C. B. Bakker, L. Halpern, and R. D. Post, Social facilitation of marijuana intoxication: impact of social set and pharmacological activity, J. Abnorm. Psychol, vol.80, pp.132-140, 1972.

C. S. Carter and D. M. Barch, Imaging biomarkers for treatment development for impaired cognition: report of the sixth CNTRICS meeting: biomarkers recommended for further development, Schizophr. Bull, vol.38, pp.26-33, 2011.

P. Casadio, C. Fernandes, R. M. Murray, and M. Di-forti, Cannabis use in young people: the risk for schizophrenia, Neurosci. Biobehav. Rev, vol.35, pp.1779-1787, 2011.

B. Cecyre, N. Zabouri, F. Huppe-gourgues, J. Bouchard, and C. Casanova, Roles of cannabinoid receptors type 1 and 2 on the retinal function of adult mice, Investig. Ophthalmol. Vis. Sci, vol.54, pp.8079-8090, 2013.

G. P. Chaves, T. C. Nogueira, L. R. Britto, S. Bordin, and A. S. Torrão, Retinal removal up-regulates cannabinoid CB(1) receptors in the chick optic tectum, J. Neurosci. Res, vol.86, pp.1626-1634, 2008.

T. Schwitzer,

-. Chen, J. Matias, I. Dinh, T. Lu, T. Venezia et al., Finding of endocannabinoids in human eye tissues: implications for glaucoma, Anomalies fonctionnelles rétiniennes dans les troubles neuropsychiatriques et leurs liens avec les dysfonctionnements cérébraux Habilitation à diriger les recherches, vol.330, pp.1062-1067, 2005.

V. Chevaleyre, K. A. Takahashi, and P. E. Castillo, Endocannabinoid-mediated synaptic plasticity in the CNS, Annu. Rev. Neurosci, vol.29, pp.37-76, 2006.

L. S. Colzato and B. Hommel, Cannabis, cocaine, and visuomotor integration: evidence for a role of dopamine D1 receptors in binding perception and action, Neuropsychologia, vol.46, pp.1570-1575, 2008.

P. Consroe, R. Musty, J. Rein, W. Tillery, and R. Pertwee, The perceived effects of smoked cannabis on patients with multiple sclerosis, Eur. Neurol, vol.38, pp.44-48, 1997.

E. Cottone, V. Pomatto, F. Cerri, E. Campantico, K. Mackie et al., Cannabinoid receptors are widely expressed in goldfish: molecular cloning of a CB2-like receptor and evaluation of CB1 and CB2 mRNA expression profiles in different organs, Fish Physiol. Biochem, vol.39, pp.1287-1296, 2013.

R. D. Crean, N. A. Crane, and B. J. Mason, An evidence-based review of acute and long-term effects of cannabis use on executive cognitive functions, J. Addict. Med, vol.5, pp.1-8, 2011.

R. A. Crozier, Y. Wang, C. Liu, and M. F. Bear, Deprivationinduced synaptic depression by distinct mechanisms in different layers of mouse visual cortex, Proc. Natl. Acad. Sci. USA, vol.104, pp.1383-1388, 2007.

M. A. Dasilva, K. L. Grieve, J. Cudeiro, and C. Rivadulla, Endocannabinoid CB1 receptors modulate visual output from the thalamus, Psychopharmacology, vol.219, pp.835-845, 2012.

W. W. Dawson, C. F. Jiménez-antillon, J. M. Perez, and J. A. Zeskind, Marijuana and vision-after ten years' use in Costa Rica, Investig. Ophthalmol. Vis. Sci, vol.16, pp.689-699, 1977.

L. Degenhardt, W. Chiu, N. Sampson, R. C. Kessler, J. C. Anthony et al., Toward a global view of alcohol, tobacco, cannabis, and cocaine use: findings from the WHO World Mental Health Surveys, PLoS Med, vol.5, 2008.

W. A. Devane, F. A. Dysarz, M. R. Johnson, L. S. Melvin, and A. C. Howlett, Determination and characterization of a cannabinoid receptor in rat brain, Mol. Pharmacol, vol.34, pp.605-613, 1988.

W. A. Devane, L. Hanus, A. Breuer, R. G. Pertwee, L. A. Stevenson et al., Isolation and structure of a brain constituent that binds to the cannabinoid receptor, Science, vol.258, pp.1946-1949, 1992.

A. A. Disney, C. Aoki, and M. J. Hawken, Gain modulation by nicotine in macaque v1, Neuron, vol.56, pp.701-713, 2007.

M. Egertová and M. R. Elphick, Localisation of cannabinoid receptors in the rat brain using antibodies to the intracellular C-terminal tail of CB, J. Comp. Neurol, vol.422, pp.159-171, 2000.

H. Ehrenreich, T. Rinn, H. J. Kunert, M. R. Moeller, W. Poser et al., Specific attentional dysfunction in adults following early start of cannabis use, Psychopharmacology, vol.142, pp.295-301, 1999.

H. M. Emrich, A three-component-system hypothesis of psychosis: Impairment of binocular depth inversion as anindicator of function disequilibrium, Br. J. Psychiatry, vol.155, pp.37-39, 1989.

H. M. Emrich, M. M. Weber, A. Wendl, J. Zihl, L. Meyer et al., Reduced binocular depth inversion as an indicator of cannabis-induced censorship impairment, Pharmacol. Biochem. Behav, vol.40, pp.689-690, 1991.

, Biphasic modulation of voltagedependent currents of retinal cones by cannabinoid CB1 receptor agonist WIN 55212-2, European Monitoring Centre for Drugs and Drug Addiction, vol.20, pp.177-188, 2003.

S. Fan and S. Yazulla, Inhibitory interaction of cannabinoid CB1 receptor and dopamine D2 receptor agonists on voltagegated currents of goldfish cones, Vis. Neurosci, vol.21, pp.69-77, 2004.

S. Fan, S. Yazulla, S. Fan, and S. Yazulla, Reciprocal inhibition of voltage-gated potassium currents (I K(V)) by activation of cannabinoid CB1 and dopamine D1 receptors in ON bipolar cells of goldfish retina, Vis. Neurosci, vol.22, pp.257-267, 2005.

C. C. Felder, K. E. Joyce, E. M. Briley, J. Mansouri, K. Mackie et al., Comparison of the pharmacology and signal transduction of the human cannabinoid CB1 and CB2 receptors, Mol. Pharmacol, vol.48, pp.443-450, 1995.

C. C. Felder, A. Nielsen, E. M. Briley, M. Palkovits, J. Priller et al., Isolation and measurement of the endogenous cannabinoid receptor agonist, anandamide, in brain and peripheral tissues of human and rat, FEBS Lett, vol.393, pp.231-235, 1996.

S. Funahashi and J. M. Andreau, Prefrontal cortex and neural mechanisms of executive function, J. Physiol, vol.107, pp.471-482, 2013.

Y. Gaoni and R. Mechoulam, Isolation, structure, and partial synthesis of an active constituent of hashish, J. Am. Chem. Soc, vol.86, pp.1646-1647, 1964.

Y. Garkun and A. Maffei, Cannabinoid-dependent potentiation of inhibition at eye opening in mouse V1, Front. Cell. Neurosci, vol.8, 2014.

A. M. Gawienowski, D. Chatterjee, P. J. Anderson, D. L. Epstein, and W. M. Grant, Effect of delta 9-tetrahydrocannabinol on monoamine oxidase activity in bovine eye tissues, in vitro, Investig. Ophthalmol. Vis. Sci, vol.22, pp.482-485, 1982.

A. Giersch and M. H. Herzog, Lorazepam strongly prolongs visual information processing, Neuropsychopharmacology, vol.29, pp.1386-1394, 2004.

S. T. Glaser, D. G. Deutsch, K. M. Studholme, S. Zimov, and S. Yazulla, Endocannabinoids in the intact retina: 3 H-anandamide uptake, fatty acid amide hydrolase immunoreactivity and hydrolysis of anandamide, Vis. Neurosci, vol.22, pp.693-705, 2005.

M. Glass, M. Dragunow, and R. L. Faull, Cannabinoid receptors in the human brain: a detailed anatomical and quantitative autoradiographic study in the fetal, neonatal and adult human brain, Neuroscience, vol.77, pp.299-318, 1997.

M. Glass and J. K. Northup, Agonist selective regulation of G proteins by cannabinoid CB(1) and CB(2) receptors. Mol. Pharmacol, vol.56, pp.1362-1369, 1999.

J. Gong, E. S. Onaivi, H. Ishiguro, Q. Liu, P. A. Tagliaferro et al., Intraocular motility, electrophysiological tests and visual fields in drug addicts, Ophthalmic Physiol. Opt, vol.1071, pp.493-498, 1995.

L. Abu-lafi, S. Fride, E. Breuer, A. Vogel, Z. Shalev et al., 2-arachidonyl glyceryl ether, an endogenous agonist of the cannabinoid CB1 receptor, The cannabinoid system and visual processing: A review on experimental findings and clinical presumptions Anomalies fonctionnelles rétiniennes dans les troubles neuropsychiatriques et leurs liens avec les dysfonctionnements cérébraux Habilitation à diriger les recherches-Thomas Schwitzer Hanus, vol.98, pp.3662-3665, 2001.

R. L. Hartman and M. A. Huestis, Cannabis effects on driving skills, Clin. Chem, vol.59, pp.478-492, 2013.

M. Herkenham, A. B. Lynn, M. R. Johnson, L. S. Melvin, B. R. De-costa et al., Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study, J. Neurosci, vol.11, pp.563-583, 1991.

M. Herkenham, A. B. Lynn, M. D. Little, M. R. Johnson, L. S. Melvin et al., Cannabinoid receptor localization in brain, Proc. Natl. Acad. Sci. USA, vol.87, pp.1932-1936, 1990.

A. G. Hohmann and M. Herkenham, Cannabinoid receptors undergo axonal flow in sensory nerves, Neuroscience, vol.92, pp.1171-1175, 1999.

G. E. Holder, G. G. Celesia, Y. Miyake, S. Tobimatsu, and R. G. Weleber, International Federation of Clinical Neurophysiology: recommendations for visual system testing, Clin. Neurophysiol, vol.121, pp.1393-1409, 2010.

V. L. Holt, K. L. Cushing-haugen, and J. R. Daling, Risk of functional ovarian cyst: effects of smoking and marijuana use according to body mass index, Am. J. Epidemiol, vol.161, pp.520-525, 2005.

M. Hoon, H. Okawa, L. Della-santina, and R. O. Wong, Functional architecture of the retina: development and disease, 2014.

. Prog and . Retin, Eye Res, vol.42, pp.44-84

A. C. Howlett, J. M. Qualy, and L. L. Khachatrian, Involvement of Gi in the inhibition of adenylate cyclase by cannabimimetic drugs, Mol. Pharmacol, vol.29, pp.307-313, 1986.

Y. Huang, H. Yasuda, A. Sarihi, and T. Tsumoto, Roles of endocannabinoids in heterosynaptic long-term depression of excitatory synaptic transmission in visual cortex of young mice, 2008.

, J. Neurosci, vol.28, pp.7074-7083, 2008.

L. Huestegge, R. Radach, H. Kunert, and D. Heller, Visual search in long-term cannabis users with early age of onset, Prog. Brain Res, vol.140, issue.02, pp.40064-40071, 2002.

M. A. Huestis, Human cannabinoid pharmacokinetics, Chem. Biodivers, vol.4, pp.1770-1804, 2007.

D. C. Javitt, When doors of perception close: bottom-up models of disrupted cognition in schizophrenia, Annu. Rev. Clin. Psychol, vol.5, pp.249-275, 2009.

B. Jiang, S. Huang, R. De-pasquale, D. Millman, L. Song et al., The maturation of GABAergic transmission in visual cortex requires endocannabinoid-mediated LTD of inhibitory inputs during a critical period, Neuron, vol.66, pp.248-259, 2010.

B. Jiang, K. Sohya, A. Sarihi, Y. Yanagawa, and T. Tsumoto, Laminar-specific maturation of GABAergic transmission and susceptibility to visual deprivation are related to endocannabinoid sensitivity in mouse visual cortex, J. Neurosci, vol.30, pp.14261-14272, 2010.

S. Katzner, L. Busse, and M. Carandini, GABAA inhibition controls response gain in visual cortex, J. Neurosci, vol.31, pp.5931-5941, 2011.

R. A. Knight and S. M. Silverstein, A process-oriented approach for averting confounds resulting from general performance deficiencies in schizophrenia, J. Abnorm. Psychol, vol.110, pp.15-30, 2001.

G. L. Laffi and A. B. Safran, Persistent visual changes following hashish consumption, Br. J. Ophthalmol, vol.77, pp.601-602, 1993.

M. R. Lalonde, C. A. Jollimore, K. Stevens, S. Barnes, and M. E. Kelly, Cannabinoid receptor-mediated inhibition of calcium signaling in rat retinal ganglion cells, Mol. Vis, vol.12, pp.1160-1166, 2006.

V. Laprevote, T. Schwitzer, A. Giersch, and R. Schwan, Flash electroretinogram and addictive disorders. Prog. Neuropsychopharmacol, Biol. Psychiatry, vol.56, 2015.

J. Lavoie, P. Illiano, T. D. Sotnikova, R. R. Gainetdinov, J. Beaulieu et al., The electroretinogram as a biomarker of central dopamine and serotonin: potential relevance to psychiatric disorders, Biol. Psychiatry, vol.75, pp.479-486, 2014.

A. G. Lerner, C. Goodman, D. Rudinski, and A. Bleich, Benign and time-limited visual disturbances (flashbacks) in recent abstinent high-potency heavy cannabis smokers: a case series study, Isr. J. Psychiatry Relat. Sci, vol.48, pp.25-29, 2011.

F. M. Leweke, U. Schneider, M. Thies, T. F. Münte, and H. M. Emrich, Effects of synthetic delta9-tetrahydrocannabinol on binocular depth inversion of natural and artificial objects in man, Psychopharmacology, vol.142, pp.230-235, 1999.

C. Liu, A. J. Heynen, M. G. Shuler, and M. F. Bear, Cannabinoid receptor blockade reveals parallel plasticity mechanisms in different layers of mouse visual cortex, Neuron, vol.58, pp.340-345, 2008.

M. Livingstone and D. Hubel, Segregation of form, color, movement, and depth: anatomy, physiology, and perception, Science, vol.240, pp.740-749, 1988.

E. M. López, P. Tagliaferro, E. S. Onaivi, and J. J. López-costa, Distribution of CB2 cannabinoid receptor in adult rat retina, Synapse, vol.65, pp.388-392, 2011.

M. D. Low, H. Klonoff, and A. Marcus, The neurophysiological basis of the marijuana experience, Can. Med. Assoc. J, vol.108, pp.157-165, 1973.

T. Lundqvist, Cognitive consequences of cannabis use: comparison with abuse of stimulants and heroin with regard to attention, memory and executive functions, Pharmacol. Biochem. Behav, vol.81, pp.319-330, 2005.

Q. Lu, A. Straiker, Q. Lu, and G. Maguire, Expression of CB2 cannabinoid receptor mRNA in adult rat retina, Vis. Neurosci, vol.17, pp.91-95, 2000.

P. Mailleux, M. Parmentier, and J. J. Vanderhaeghen, Distribution of cannabinoid receptor messenger RNA in the human brain: an in situ hybridization histochemistry with oligonucleotides, Neurosci. Lett, vol.143, pp.200-204, 1992.

M. F. Marmor, A. B. Fulton, G. E. Holder, Y. Miyake, M. Brigell et al., International Society for Clinical Electrophysiology of Vision, update). Doc. Ophthalmol, vol.118, pp.69-77, 2008.

V. D. Marzo, M. Bifulco, and L. D. Petrocellis, The endocannabinoid system and its therapeutic exploitation, Nat. Rev. Drug Discov, vol.3, pp.771-784, 2004.

I. Matias, J. W. Wang, A. S. Moriello, A. Nieves, D. F. Woodward et al., Changes in endocannabinoid and palmitoylethanolamide levels in eye tissues of patients with diabetic retinopathy and age-related macular degeneration, Prostaglandins Leukot. Essent. Fatty Acids, vol.75, pp.413-418, 2006.

L. A. Matsuda, S. J. Lolait, M. J. Brownstein, A. C. Young, and T. I. Bonner, Structure of a cannabinoid receptor and functional expression of the cloned cDNA, Nature, vol.346, pp.561-564, 1990.

S. Matsuda, N. Kanemitsu, A. Nakamura, Y. Mimura, N. Ueda et al., Metabolism of anandamide, an endogenous cannabinoid receptor ligand, in porcine ocular tissues, Exp. Eye Res, vol.64, pp.707-711, 1997.

T. Schwitzer,

R. Braun, P. Gaoni, and Y. , Stereospecific synthesis of (-)-.DELTA.1-and (-)-.DELTA.1(6)-tetrahydrocannabinols, Anomalies fonctionnelles rétiniennes dans les troubles neuropsychiatriques et leurs liens avec les dysfonctionnements cérébraux Habilitation à diriger les recherches-Thomas Schwitzer Mechoulam, vol.89, pp.4552-4554, 1967.

R. Mechoulam and L. Hanus, A historical overview of chemical research on cannabinoids, Chem. Phys. Lipids, vol.108, pp.1-13, 2000.

R. Mechoulam and L. A. Parker, The endocannabinoid system and the brain, Annu. Rev. Psychol, vol.64, pp.21-47, 2013.

R. Mechoulam and Y. Shvo, Hashish-I: the structure of cannabidiol, Tetrahedron, vol.19, issue.63, p.85022, 1963.

R. Mehra, B. A. Moore, K. Crothers, J. Tetrault, and D. A. Fiellin, The association between marijuana smoking and lung cancer: a systematic review, Arch. Intern. Med, vol.166, pp.1359-1367, 2006.

M. H. Meier, A. Caspi, A. Ambler, H. Harrington, R. Houts et al., Persistent cannabis users show neuropsychological decline from childhood to midlife, Proc. Natl. Acad. Sci. USA, vol.109, pp.2657-2664, 2012.

T. P. Middleton, D. A. Protti, G. Moldrich, and T. Wenger, Localization of the CB1 cannabinoid receptor in the rat brain. An immunohistochemical study, Vis. Neurosci, vol.28, pp.1735-1742, 2000.

T. H. Moore, S. Zammit, A. Lingford-hughes, T. R. Barnes, P. B. Jones et al., Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review, Lancet, vol.370, issue.07, pp.61162-61165, 2007.

S. Munro, K. L. Thomas, and M. Abu-shaar, Molecular characterization of a peripheral receptor for cannabinoids, Nature, vol.365, pp.61-65, 1993.

L. G. Nowak, A. C. James, and J. Bullier, Corticocortical connections between visual areas 17 and 18a of the rat studied in vitro: spatial and temporal organisation of functional synaptic responses, Exp. Brain Res, vol.117, pp.219-241, 1997.

R. Noyes, S. F. Brunk, D. A. Avery, and A. C. Canter, The analgesic properties of delta-9-tetrahydrocannabinol and codeine, Clin. Pharmacol. Ther, vol.18, pp.84-89, 1975.

I. E. Ohiorhenuan, F. Mechler, K. P. Purpura, A. M. Schmid, Q. Hu et al., Cannabinoid neuromodulation in the adult early visual cortex, PLoS One, vol.9, 2014.

E. S. Onaivi, H. Ishiguro, J. Gong, S. Patel, P. A. Meozzi et al., Brain neuronal CB2 cannabinoid receptors in drug abuse and depression: from mice to human subjects, PLoS One, vol.3, 2008.

E. S. Onaivi, H. Ishiguro, J. Gong, S. Patel, A. Perchuk et al., Discovery of the presence and functional expression of cannabinoid CB2 receptors in brain, Ann. N. Y. Acad. Sci, vol.1074, pp.514-536, 2006.

W. Y. Ong and K. Mackie, A light and electron microscopic study of the CB1 cannabinoid receptor in primate brain, Neuroscience, vol.92, pp.1177-1191, 1999.

C. A. Opere, W. D. Zheng, M. Zhao, J. S. Lee, K. H. Kulkarni et al., Inhibition of potassium-and ischemia-evoked [ 3 H] Daspartate release from isolated bovine retina by cannabinoids, Curr. Eye Res, vol.31, pp.645-653, 2006.

K. Palczewski, Chemistry and Biology of Vision, J. Biol. Chem, vol.287, pp.1612-1619, 2011.

G. Patrick, J. J. Straumanis, F. A. Struve, F. Nixon, M. J. Fitz-gerald et al., Auditory and visual P300 event related potentials are not altered in medically and psychiatrically normal chronic marihuana users, Life Sci, vol.56, pp.2135-2140, 1995.

T. Pattij, J. Wiskerke, and A. N. Schoffelmeer, Cannabinoid modulation of executive functions, Eur. J. Pharmacol, vol.585, pp.458-463, 2008.

J. Polich, Updating P300: an integrative theory of P3a and P3b, Clin. Neurophysiol, vol.118, pp.2128-2148, 2007.

A. Porcella, P. Casellas, G. L. Gessa, and L. Pani, Cannabinoid receptor CB1 mRNA is highly expressed in the rat ciliary body: implications for the antiglaucoma properties of marihuana, Brain Res. Mol. Brain Res, vol.58, pp.240-245, 1998.

A. Porcella, C. Maxia, G. L. Gessa, and L. Pani, The human eye expresses high levels of CB1 cannabinoid receptor mRNA and protein, Eur. J. Neurosci, vol.12, pp.1123-1127, 2000.

D. J. Potter, P. Clark, and M. B. Brown, Potency of delta 9-THC and other cannabinoids in cannabis in England in 2005: implications for psychoactivity and pharmacology, J. Forensic Sci, vol.53, pp.90-94, 2008.

E. Raes and A. Verstraete, Cannabis and driving: the situation in Europe, Ann. Pharm. Fr, vol.64, pp.197-203, 2006.

R. A. Ross, A. A. Coutts, S. M. Mcfarlane, S. Anavi-goffer, A. J. Irving et al., Actions of cannabinoid receptor ligands on rat cultured sensory neurones: implications for antinociception, Neuropharmacology, vol.40, pp.221-232, 2001.

E. B. Russo, A. Merzouki, J. M. Mesa, K. A. Frey, and P. J. Bach, Cannabis improves night vision: a case study of dark adaptometry and scotopic sensitivity in kif smokers of the Rif mountains of northern Morocco, J. Ethnopharmacol, vol.93, pp.99-104, 2004.

M. Sauvanier, J. Constans, S. Skopinski, D. Barcat, A. Berard et al., Lower limb occlusive arteriopathy: retrospective analysis of 73 patients with onset before the age of 50 years, J. Mal. Vasc, vol.27, pp.69-76, 2002.

E. Schlicker, J. Timm, and M. Göthert, Cannabinoid receptormediated inhibition of dopamine release in the retina, Naunyn Schmiedebergs Arch. Pharmacol, vol.354, pp.791-795, 1996.

U. Schneider, M. Borsutzky, J. Seifert, F. M. Leweke, T. J. Huber et al., Reduced binocular depth inversion in schizophrenic patients, Schizophr. Res, vol.53, pp.101-108, 2002.

U. Schneider, D. E. Dietrich, U. Sternemann, I. Seeland, D. Gielsdorf et al., Reduced binocular depth inversion in patients with alcoholism, Alcohol Alcohol, vol.33, pp.168-172, 1998.

C. D. Schubart, I. E. Sommer, P. Fusar-poli, L. De-witte, R. S. Kahn et al., Cannabidiol as a potential treatment for psychosis, Eur. Neuropsychopharmacol, vol.24, pp.51-64, 2014.

D. M. Semple, F. Ramsden, and A. M. Mcintosh, Reduced binocular depth inversion in regular cannabis users, Pharmacol. Biochem. Behav, vol.75, pp.789-793, 2003.

S. M. Sherman and R. W. Guillery, The role of the thalamus in the flow of information to the cortex, Philos. Trans. R. Soc. Lond. B, vol.357, pp.1695-1708, 2002.

G. Simon, L. Petit, C. Bernard, and M. Rebaï, N170 ERPs could represent a logographic processing strategy in visual word recognition, Behav. Brain Funct, vol.3, 2007.

P. Skosnik, G. Krishnan, J. Vohs, and B. Odonnell, The effect of cannabis use and gender on the visual steady state evoked potential, Clin. Neurophysiol, vol.117, pp.144-156, 2006.

N. Battisti and R. , The chronic effects of cannabis on memory in humans: a review, The cannabinoid system and visual processing: A review on experimental findings and clinical presumptions Anomalies fonctionnelles rétiniennes dans les troubles neuropsychiatriques et leurs liens avec les dysfonctionnements cérébraux Habilitation à diriger les recherches-Thomas Schwitzer Solowij, vol.1, pp.81-98, 2008.

N. Solowij, P. T. Michie, and A. M. Fox, Differential impairments of selective attention due to frequency and duration of cannabis use, Biol. Psychiatry, vol.37, pp.178-184, 1995.

D. C. Somers and S. L. Sheremata, Attention maps in the brain, Wiley Interdiscip. Rev, vol.4, pp.327-340, 2013.

W. D. Stamer, S. F. Golightly, Y. Hosohata, E. P. Ryan, A. C. Porter et al., Cannabinoid CB(1) receptor expression, activation and detection of endogenous ligand in trabecular meshwork and ciliary process tissues, Eur. J. Pharmacol, vol.431, pp.277-286, 2001.

A. J. Straiker, G. Maguire, K. Mackie, and J. Lindsey, Localization of cannabinoid CB1 receptors in the human anterior eye and retina, Investig. Ophthalmol. Vis. Sci, vol.40, pp.2442-2448, 1999.

A. Straiker and K. Mackie, Cannabinoids, electrophysiology, and retrograde messengers: challenges for the next 5 years, AAPS J, vol.8, pp.272-276, 2006.

A. Straiker, N. Stella, D. Piomelli, K. Mackie, H. J. Karten et al., Cannabinoid CB1 receptors and ligands in vertebrate retina: localization and function of an endogenous signaling system, Proc. Natl. Acad. Sci. USA 96, pp.14565-14570, 1999.

A. Straiker and J. M. Sullivan, Cannabinoid receptor activation differentially modulates ion channels in photoreceptors of the tiger salamander, J. Neurophysiol, vol.89, pp.2647-2654, 2003.

M. L. Struik, S. Yazulla, and M. Kamermans, Cannabinoid agonist WIN 55212-2 speeds up the cone response to light offset in goldfish retina, Vis. Neurosci, vol.23, pp.285-293, 2006.

T. Sugiura and K. Waku, 2-Arachidonoylglycerol and the cannabinoid receptors, Chem. Phys. Lipids, vol.108, pp.89-106, 2000.

J. M. Tetrault, K. Crothers, B. A. Moore, R. Mehra, J. Concato et al., Effects of marijuana smoking on pulmonary function and respiratory complications: a systematic review, Arch. Intern. Med, vol.167, pp.221-228, 2007.

R. B. Tootell, S. L. Hamilton, and E. Switkes, Functional anatomy of macaque striate cortex. IV. Contrast and magno-parvo streams, J. Neurosci, vol.8, pp.1594-1609, 1988.

K. Tsou, S. Brown, M. C. Sañudo-peña, K. Mackie, and J. M. Walker, Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system, Neuroscience, vol.83, pp.393-411, 1998.

M. Valenti, E. Cottone, R. Martinez, N. De-pedro, M. Rubio et al., The endocannabinoid system in the brain of Carassius auratus and its possible role in the control of food intake, J. Neurochem, vol.95, pp.329-332, 2005.

A. Verdejo-garcía, C. Rivas-pérez, F. López-torrecillas, and M. Pérez-garcía, Differential impact of severity of drug use on frontal behavioral symptoms, Addict. Behav, vol.31, pp.1373-1382, 2006.

P. P. Vescovi, M. Pedrazzoni, M. Michelini, L. Maninetti, F. Bernardelli et al., Chronic effects of marihuana smoking on luteinizing hormone, follicle-stimulating hormone and prolactin levels in human males, Drug Alcohol Depend, vol.30, pp.59-63, 1992.

B. Weber and E. Schlicker, Modulation of dopamine release in the guinea-pig retina by G(i)-but not by G(s)-or G(q)-proteincoupled receptors, Fundam. Clin. Pharmacol, vol.15, pp.393-400, 2001.

A. T. Weil, N. E. Zinberg, and J. M. Nelsen, Clinical and psychological effects of marijuana in man, Subst. Use Misuse, vol.4, pp.427-451, 1969.

Y. Wei, X. Wang, and L. Wang, Presence and regulation of cannabinoid receptors in human retinal pigment epithelial cells, Mol. Vis, vol.15, pp.1243-1251, 2009.

Y. Wei, X. Wang, F. Zhao, P. Zhao, and X. Kang, Cannabinoid receptor 1 blockade protects human retinal pigment epithelial cells from oxidative injury, Mol. Vis, vol.19, pp.357-366, 2013.

K. A. Welch, A. C. Stanfield, A. M. Mcintosh, H. C. Whalley, D. E. Job et al., Impact of cannabis use on thalamic volume in people at familial high risk of schizophrenia, Br. J. Psychiatry, vol.199, pp.386-390, 2011.

T. M. Westlake, A. C. Howlett, T. I. Bonner, L. A. Matsuda, and M. Herkenham, Cannabinoid receptor binding and messenger RNA expression in human brain: an in vitro receptor autoradiography and in situ hybridization histochemistry study of normal aged and Alzheimer's brains, Neuroscience, vol.63, pp.90511-90519, 1994.

M. E. West, Cannabis and night vision, Nature, vol.351, pp.703-704, 1991.

R. I. Wilson and R. A. Nicoll, Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses, Nature, vol.410, pp.588-592, 2001.

T. T. Winton-brown, P. Allen, S. Bhattacharyya, S. J. Borgwardt, P. Fusar-poli et al., Modulation of auditory and visual processing by delta-9-tetrahydrocannabinol and cannabidiol: an FMRI study, Neuropsychopharmacology, vol.36, pp.1340-1348, 2011.
URL : https://hal.archives-ouvertes.fr/hal-00624169

S. Yazulla, Endocannabinoids in the retina: from marijuana to neuroprotection, Prog. Retin. Eye Res, vol.27, pp.501-526, 2008.

S. Yazulla, K. M. Studholme, H. H. Mcintosh, and S. F. Fan, Cannabinoid receptors on goldfish retinal bipolar cells: electron-microscope immunocytochemistry and whole-cell recordings, Vis. Neurosci, vol.17, pp.391-401, 2000.

T. Yoneda, K. Kameyama, K. Esumi, Y. Daimyo, M. Watanabe et al., Developmental and visual input-dependent regulation of the CB1 cannabinoid receptor in the mouse visual cortex, PLoS One, vol.8, 2013.

J. H. Yoon, S. L. Sheremata, A. Rokem, and M. A. Silver, Windows to the soul: vision science as a tool for studying biological mechanisms of information processing deficits in schizophrenia, Front. Psychol, vol.4, p.681, 2013.

N. Zabouri, J. Bouchard, and C. Casanova, Cannabinoid receptor type 1 expression during postnatal development of the rat retina, J. Comp. Neurol, vol.519, pp.1258-1280, 2011.

C. Zhang, H. Wu, S. Wang, S. Yin, X. Lu et al., Suppression of outward K + currents by WIN55212-2 in rat retinal ganglion cells is independent of CB1/CB2 receptors, Neuroscience, vol.253, pp.183-193, 2013.

T. Schwitzer,

M. Hoon, H. Okawa, D. Santina, L. Wong, and R. , Functional architecture of the retina: development and disease, Prog Retin Eye Res, vol.42, pp.44-84, 2014.

A. References-agrawal, A. J. Budney, M. T. Lynskey, M. Bach, M. G. Brigell et al., ISCEV standard for clinical pattern electroretinography (PERG): 2012 update, Doc. Ophthalmol. Adv. Ophthalmol, vol.107, pp.1-7, 2012.

M. G. Bossong and R. J. Niesink, Adolescent brain maturation, the endogenous cannabinoid system and the neurobiology of cannabis-induced schizophrenia, Prog. Neurobiol, vol.92, pp.370-385, 2010.

S. J. Broyd, H. H. Van-hell, C. Beale, M. Yücel, and N. Solowij, Acute and chronic effects of cannabinoids on human cognition-a systematic review, Biol. Psychiatry, vol.79, pp.557-567, 2016.

E. Bubl, D. Ebert, E. Kern, L. T. Van-elst, and M. Bach, Effect of antidepressive therapy on retinal contrast processing in depressive disorder, Br. J. Psychiatry J. Ment. Sci, vol.201, pp.151-158, 2012.

E. Bubl, E. Kern, D. Ebert, M. Bach, and L. Tebartz-van-elst, Seeing gray when feeling Blue? Depression can Be measured in the eye of the diseased, Biol. Psychiatry, vol.68, pp.205-208, 2010.

E. Bubl, E. Kern, D. Ebert, A. Riedel, L. Tebartz-van-elst et al., Retinal dysfunction of contrast processing in major depression also apparent in cortical activity, Eur. Arch. Psychiatry Clin. Neurosci, vol.265, pp.343-350, 2015.

B. Cecyre, N. Zabouri, F. Huppe-gourgues, J. Bouchard, and C. Casanova, Roles of cannabinoid receptors type 1 and 2 on the retinal function of adult mice, Invest. Ophthalmol. Vis. Sci, vol.54, pp.8079-8090, 2013.

G. G. Celesia, D. Kaufman, and S. B. Cone, Simultaneous recording of pattern electroretinography and visual evoked potentials in multiple sclerosis. A method to separate demyelination from axonal damage to the optic nerve, Arch. Neurol, vol.43, pp.1247-1252, 1986.

C. F. De-souza, M. L. Acosta, P. J. Polkinghorne, C. N. Mcghee, and M. Kalloniatis, Amino acid immunoreactivity in normal human retina and after brachytherapy, Clin. Exp. Optom. J. Aust. Optom. Assoc, vol.96, pp.504-507, 2013.

L. Degenhardt, W. Chiu, N. Sampson, R. C. Kessler, J. C. Anthony et al., Toward a global view of alcohol, tobacco, cannabis, and cocaine use: findings from the WHO World Mental Health Surveys, PLoS Med, vol.5, 2008.

J. Froehlich and D. I. Kaufman, Use of pattern electroretinography to differentiate acute optic neuritis from acute anterior ischemic optic neuropathy, Electroencephalogr. Clin. Neurophysiol, vol.92, pp.480-486, 1994.

J. Froehlich and D. I. Kaufman, The pattern electroretinogram: N95 amplitudes in normal subjects and optic neuritis patients, Electroencephalogr. Clin. Neurophysiol, vol.88, pp.83-91, 1993.

E. Garcia-martin, D. Rodriguez-mena, M. Satue, C. Almarcegui, I. Dolz et al., Electrophysiology and optical coherence tomography to evaluate Parkinson disease severity, Invest. Ophthalmol. Vis. Sci, vol.55, pp.696-705, 2014.

G. E. Holder, G. G. Celesia, Y. Miyake, S. Tobimatsu, and R. G. Weleber, International Federation of Clinical Anomalies fonctionnelles rétiniennes dans les troubles neuropsychiatriques et leurs liens avec les dysfonctionnements cérébraux Habilitation à diriger les recherches-Thomas Schwitzer Neurophysiology: recommendations for visual system testing, Clin. Neurophysiol. Off. J. Int. Fed. Clin. Neurophysiol, vol.121, pp.1393-1409, 2010.

G. E. Holder, R. P. Gale, J. F. Acheson, and A. G. Robson, Electrodiagnostic assessment in optic nerve disease, Curr. Opin. Neurol, vol.22, pp.3-10, 2009.

M. Hoon, H. Okawa, L. Della-santina, and R. O. Wong, Functional architecture of the retina: development and disease, Prog. Retin. Eye Res, vol.42, pp.44-84, 2014.

K. Krasodomska, W. Lubi?ski, A. Potemkowski, and K. Honczarenko, Pattern electroretinogram (PERG) and pattern visual evoked potential (PVEP) in the early stages of Alzheimer's disease, Doc. Ophthalmol. Adv. Ophthalmol, vol.121, pp.111-121, 2010.

J. Lavoie, P. Illiano, T. D. Sotnikova, R. R. Gainetdinov, J. Beaulieu et al., The electroretinogram as a biomarker of central dopamine and serotonin: potential relevance to psychiatric disorders, Biol. Psychiatry, vol.75, pp.479-486, 2014.

J. Lavoie, M. Maziade, and M. Hébert, The brain through the retina: the flash electroretinogram as a tool to investigate psychiatric disorders, Prog. Neuro Psychopharmacol. Biol. Psychiatry, vol.48, pp.129-134, 2014.

A. London, I. Benhar, and M. Schwartz, The retina as a window to the brain-from eye research to CNS disorders, Nat. Rev. Neurol, vol.9, pp.44-53, 2013.

D. L. Mcculloch, M. F. Marmor, M. G. Brigell, R. Hamilton, G. E. Holder et al., ISCEV Standard for full-field clinical electroretinography (2015 update), Doc. Ophthalmol. Adv. Ophthalmol, vol.130, pp.1-12, 2015.

M. H. Meier, A. Caspi, A. Ambler, H. Harrington, R. Houts et al., Persistent cannabis users show neuropsychological decline from childhood to midlife, Proc. Natl. Acad. Sci, vol.109, pp.2657-2664, 2012.

T. P. Middleton and D. A. Protti, Cannabinoids modulate spontaneous synaptic activity in retinal ganglion cells, Vis. Neurosci, vol.28, pp.393-402, 2011.

V. Parisi, R. Restuccia, F. Fattapposta, C. Mina, M. G. Bucci et al., Morphological and functional retinal impairment in Alzheimer's disease patients, Clin. Neurophysiol. Off. J. Int. Fed. Clin. Neurophysiol, vol.112, pp.1860-1867, 2001.

A. Peppe, P. Stanzione, M. Pierantozzi, R. Semprini, A. Bassi et al., Does pattern electroretinogram spatial tuning alteration in Parkinson's disease depend on motor disturbances or retinal dopaminergic loss?, Electroencephalogr. Clin. Neurophysiol, vol.106, pp.374-382, 1998.

A. Peppe, P. Stanzione, F. Pierelli, D. De-angelis, M. Pierantozzi et al., Visual alterations in de novo Parkinson's disease: pattern electroretinogram latencies are more delayed and more reversible by levodopa than are visual evoked potentials, Neurology, vol.45, pp.1144-1148, 1995.

V. Porciatti, Electrophysiological assessment of retinal ganglion cell function, Exp. Eye Res, vol.141, pp.164-170, 2015.

T. Schwitzer, J. Lavoie, A. Giersch, R. Schwan, and V. Laprevote, The emerging field of retinal electrophysiological measurements in psychiatric research: a review of the findings and the perspectives in major depressive disorder, J. Psychiatr. Res, vol.70, pp.113-120, 2015.

T. Schwitzer, R. Schwan, E. Albuisson, A. Giersch, L. Lalanne et al., Association between regular cannabis use and ganglion cell dysfunction, JAMA Ophthalmol, vol.135, pp.54-60, 2017.

T. Schwitzer, R. Schwan, K. Angioi-duprez, A. Giersch, and V. Laprevote, The endocannabinoid system in the retina: from physiology to practical and therapeutic applications, Neural Plast, 2016.

T. Schwitzer, R. Schwan, K. Angioi-duprez, I. Ingster-moati, L. Lalanne et al., The cannabinoid system and visual processing: a review on experimental findings and clinical presumptions, Eur. Neuropsychopharmacol. J. Eur. Coll. Neuropsychopharmacol, vol.25, pp.100-112, 2015.

T. Schwitzer, R. Schwan, F. Bernardin, C. Jeantet, K. Angioi-duprez et al., Commentary: anatomical constitution of sense organs as a marker of mental disorders, Front. Behav. Neurosci, vol.10, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01586834

T. Schwitzer, R. Schwan, E. Bubl, L. Lalanne, K. Angioi-duprez et al., Looking into the brain through the retinal ganglion cells in psychiatric disorders: a review of evidences, Prog. Neuro Psychopharmacol. Biol. Psychiatry, 2017.

A. J. Straiker, G. Maguire, K. Mackie, and J. Lindsey, Localization of cannabinoid CB1 receptors in the human anterior eye and retina, Invest. Ophthalmol. Vis. Sci, vol.40, pp.2442-2448, 1999.

S. B. Varghese, J. C. Reid, E. E. Hartmann, and K. T. Keyser, The effects of nicotine on the human electroretinogram, Invest. Ophthalmol. Vis. Sci, vol.52, pp.9445-9451, 2011.

S. Yazulla, Endocannabinoids in the retina: from marijuana to neuroprotection, Prog. Retin. Eye Res, vol.27, pp.501-526, 2008.

T. Schwitzer,

U. Interpsy, F. Lorraine, C. Krieg, and . Cnrs-umr-7039, Anomalies fonctionnelles rétiniennes dans les troubles neuropsychiatriques et leurs liens avec les dysfonctionnements cérébraux Habilitation à diriger les recherches-Thomas Schwitzer Jeantet

. Grant, ANR and MILDECA is the French Mission Interministérielle de Lutte contre les Drogues et les Conduites Addictives; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript

R. Bodis-wollner and I. , Retinopathy in Parkinson Disease, J. Neural Transm, vol.116, issue.11, p.1493501, 2009.

M. G. Bossong and R. J. Niesink, Adolescent brain maturation, the endogenous cannabinoid system and the neurobiology of cannabis-induced schizophrenia, Prog Neurobiol, vol.92, issue.3, p.37085, 2010.

S. J. Broyd, H. H. Van-hell, C. Beale, M. Yücel, and N. Solowij, Acute and Chronic Effects of Cannabinoids on Human Cognition-a Systematic Review, Biol Psychiatry, vol.79, issue.7, p.55767, 2016.

E. Bubl, M. Dörr, A. Riedel, D. Ebert, A. Philipsen et al., Elevated background noise in adult attention deficit hyperactivity disorder is associated with inattention, PLoS One, vol.10, issue.2, p.118271, 2015.

E. J. Burnett, L. J. Chandler, and H. Trantham-davidson, Glutamatergic plasticity and alcohol dependence-induced alterations in reward, affect and cognition, Prog Neuropsychopharmacol Biol Psychiatry, vol.65, p.30920, 2016.

M. Colizzi, P. Mcguire, R. G. Pertwee, and S. Bhattacharyya, Effect of cannabis on glutamate signalling in the brain: a systematic review of human and animal evidence, Neurosci Biobehav Rev. mai, vol.64, p.35981, 2016.

J. A. Cortes-briones, J. D. Cahill, P. D. Skosnik, D. H. Mathalon, A. Williams et al., The psychosis-like effects of ?(9)-tetrahydrocannabinol are associated with increased cortical noise in healthy humans, Biol Psychiatry, vol.78, issue.11, p.80513, 2015.

L. Degenhardt, W. Chiu, N. Sampson, R. C. Kessler, J. C. Anthony et al., Toward a global view of alcohol, tobacco, cannabis, and cocaine use: findings from the WHO World Mental Health surveys, PLoS Med, vol.5, p.141, 2008.

J. A. Engel and E. Jerlhag, Alcohol: mechanisms along the mesolimbic dopamine system, Prog. Brain Res, vol.211, 2014.

H. Forssberg, E. Fernell, S. Waters, N. Waters, and J. Tedroff, Altered pattern of brain dopamine synthesis in male adolescents with attention deficit hyperactivity disorder, Behav Brain Funct BBF, vol.2, p.40, 2006.

M. F. Ghilardi, M. S. Marx, I. Bodis-wollner, C. B. Camras, and A. A. Glover, The effect of intraocular 6-hydroxydopamine on retinal processing of primates, Ann Neurol, vol.25, issue.4, p.35764, 1989.

G. E. Holder, G. G. Celesia, Y. Miyake, S. Tobimatsu, and R. G. Weleber, International Federation of Clinical Neurophysiology. International Federation of Clinical Neurophysiology: recommendations for visual system testing, Clin Neurophysiol Off J Int Fed Clin Neurophysiol, vol.121, issue.9, p.1393409, 2010.

M. Hoon, H. Okawa, L. Della-santina, and R. O. Wong, Functional architecture of the retina: development and disease, Prog Retin Eye Res, vol.42, p.4484, 2014.

H. Ikeda, Effects of ethyl alcohol on the evoked potential of the human eye, Vision Res, vol.4, issue.3, p.15569, 1963.

V. Laprevote, T. Schwitzer, A. Giersch, and R. Schwan, Flash electroretinogram and addictive disorders, Prog. Neuro-Psychopharmacol. Biol. Psychiatry, vol.56, p.264, 2015.

V. Laprevote, R. Schwan, T. Schwitzer, B. Rolland, and J. Thome, Is there a place for Off-Label Pharmacotherapy in Cannabis Use Disorder? A Review on Efficacy and Safety, Curr. Pharm. Des, vol.21, pp.3298-3305, 2015.

V. Laprevote, L. Bon, J. Krieg, T. Schwitzer, S. Bourion-bedes et al., Association between increased EEG signal complexity and cannabis dependence, Eur. Neuropsychopharmacol, vol.27, issue.12, pp.1216-1222, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01661893

A. London, I. Benhar, M. Schwartz, D. L. Mcculloch, M. F. Marmor et al., The retina as a window to the brain-from eye research to CNS disorders, Nat Rev Neurol, vol.9, issue.1, p.4453, 2013.

, Doc Ophthalmol Adv Ophthalmol. févr, vol.130, issue.1, p.112

M. J. Mckellar, R. R. Hidajat, and M. J. Elder, Acute ocular methanol toxicity: clinical and electrophysiological features, Aust N Z J Ophthalmol. août, vol.25, issue.3, p.22530, 1997.

M. H. Meier, A. Caspi, A. Ambler, H. Harrington, R. Houts et al., Persistent cannabis users show neuropsychological decline from childhood to midlife, Proc. Natl. Acad. Sci. U. S. A, vol.109, issue.40, pp.2657-2664, 2012.

T. Meigen and M. Bach, On the statistical significance of electrophysiological steadystate responses, Doc Ophthalmol Adv Ophthalmol, vol.98, issue.3, p.20732, 1999.

M. Roberto and F. P. Varodayan, Synaptic targets: Chronic alcohol actions, Neuropharmacology. 1 août, vol.122, p.8599, 2017.

T. Schwitzer, J. Lavoie, A. Giersch, R. Schwan, and V. Laprevote, The emerging field of retinal electrophysiological measurements in psychiatric research: a review of the findings and the perspectives in major depressive disorder, J Psychiatr Res, vol.70, p.11320, 2015.

T. Schwitzer, R. Schwan, K. Angioi-duprez, I. Ingster-moati, L. Lalanne et al., The cannabinoid system and visual processing: a review on experimental findings and clinical presumptions, Eur Neuropsychopharmacol J Eur Coll Neuropsychopharmacol, vol.25, issue.1, p.10012, 2015.

T. Schwitzer, M. P. Robert, A. Giersch, K. Angioi-duprez, I. Ingster-moati et al., Transient Retinal Dysfunctions after Acute Cannabis Use, Eur. Addict. Res, vol.22, issue.6, p.28791, 2016.

T. Schwitzer, R. Schwan, K. Angioi-duprez, A. Giersch, and V. Laprevote, The Endocannabinoid System in the Retina: from Physiology to Practical and Therapeutic applications, Neural Plast, 2016.

T. Schwitzer, R. Schwan, F. Bernardin, C. Jeantet, K. Angioi-duprez et al., Commentary: Anatomical constitution of sense organs as a marker of mental disorders, Front. Behav. Neurosci, vol.10, p.56, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01586834

T. Schwitzer, R. Schwan, E. Bubl, L. Lalanne, K. Angioi-duprez et al., Looking into the brain through the retinal ganglion cells in psychiatric disorders: a review of evidences, Prog Neuropsychopharmacol Biol Psychiatry, vol.76, p.15562, 2017.

T. Schwitzer, R. Schwan, E. Albuisson, A. Giersch, L. Lalanne et al., Association between regular Cannabis Use and Ganglion Cell Dysfunction, JAMA Ophthalmol, vol.135, issue.1, pp.54-60, 2017.

T. Schwitzer, R. Schwan, K. Angioi-duprez, A. Giersch, L. Lalanne et al., Delayed bipolar and ganglion cells neuroretinal processing in regular cannabis users: the retina as a relevant site to investigate brain synaptic transmission dysfunctions, J Psychiatr Res. août, vol.103, pp.75-82, 2018.

P. K. Thanos, N. D. Volkow, P. Freimuth, H. Umegaki, H. Ikari et al., Overexpression of dopamine D2 receptors reduces alcohol self-administration, Alcohol Fayettev N, vol.78, issue.5, p.7739, 2001.

N. D. Volkow, G. Wang, J. S. Fowler, F. Telang, L. Maynard et al., Evidence that methylphenidate enhances the saliency of a mathematical task by increasing dopamine in the human brain, Am J Psychiatry, vol.161, issue.7, p.117380, 2004.

N. D. Volkow, G. Wang, D. Tomasi, S. H. Kollins, T. L. Wigal et al., Methylphenidate-elicited dopamine increases in ventral striatum are associated with long-term symptom improvement in adults with attention deficit hyperactivity disorder, J Neurosci Off J Soc Neurosci, vol.18, issue.32, p.8419, 2012.

S. Yazulla, Endocannabinoids in the retina: from marijuana to neuroprotection, Prog Retin Eye Res. sept, vol.27, issue.5, p.50126, 2008.

A. Lucas, The co-occurring use and misuse of cannabis and tobacco: a review, Addict. Abingdon Engl, vol.107, p.1233, 1221.

F. J. Ascaso, N. Cruz, P. J. Modrego, R. Lopez-anton, J. Santabárbara et al., Retinal alterations in mild cognitive impairment and Alzheimer s disease: an optical coherence tomography study, J. Neurol, vol.261, p.1530, 2014.

N. Auclair, S. Otani, P. Soubrie, F. Crepel, M. Bach et al., Cannabinoids modulate synaptic strength and plasticity at glutamatergic synapses of rat prefrontal cortex pyramidal neurons, Doc. Ophthalmol. Adv. Ophthalmol, vol.83, p.3293, 2000.

A. Baghaie, Z. Yu, and R. M. Souza, State-of-the-art in retinal optical coherence tomography image analysis. Quant, Imaging Med. Surg, vol.5, p.617, 2015.

A. Baghaie, Z. Yu, and R. M. Souza, State-of-the-art in retinal optical coherence tomography image analysis. Quant, Imaging Med. Surg, vol.5, p.617, 2015.

Z. Balogh, G. Benedek, and S. Kéri, Retinal dysfunctions in schizophrenia, Prog. Neuropsychopharmacol. Biol. Psychiatry, vol.32, p.300, 2008.

D. Baylor, How photons start vision, Proc. Natl. Acad. Sci. U. S. A, vol.93, p.565, 1996.

J. Beaulieu and R. R. Gainetdinov, The physiology, signaling, and pharmacology of dopamine receptors, Pharmacol. Rev, vol.63, p.217, 2011.

F. Bernardin, R. Schwan, L. Lalanne, F. Ligier, K. Angioi-duprez et al., The role of the retina in visual hallucinations: a review of the literature and implications for psychosis, Neuropsychologia, vol.99, p.138, 2017.
URL : https://hal.archives-ouvertes.fr/hal-02337395

, Anomalies fonctionnelles rétiniennes dans les troubles neuropsychiatriques et leurs liens avec les dysfonctionnements

T. Schwitzer, Neuroscience and Biobehavioral Reviews xxx, 2018.

I. Bodis-wollner and M. D. Yahr, Measurements of visual evoked potentials in Parkinson s disease, Brain J. Neurol, vol.101, p.671, 1978.

I. Bodis-wollner, M. S. Marx, S. Mitra, P. Bobak, L. Mylin et al., Visual dysfunction in Parkinson s disease. Loss in spatiotemporal contrast sensitivity, Brain J. Neurol, vol.110, p.1698, 1987.

D. O. Borroto-escuela, J. Pintsuk, T. Schäfer, K. Friedland, L. Ferraro et al., Multiple D2 heteroreceptor complexes: new targets for treatment of schizophrenia, Ther. Adv. Psychopharmacol, vol.6, p.94, 2016.

M. G. Bossong, R. J. Niesink, ;. B. Wässle, and H. , Adolescent brain maturation, the endogenous cannabinoid system and the neurobiology of cannabis-induced schizophrenia, Invest. Ophthalmol. Vis. Sci, vol.92, p.1327, 1999.

C. Brandon and D. M. Lam, L-glutamic acid: a neurotransmitter candidate for cone photoreceptors in human and rat retinas, Proc. Natl. Acad. Sci. U. S. A, vol.80, p.5121, 1983.

D. Brites and A. Fernandes, Neuroinaammation and depression: microglia activation, extracellular microvesicles and microRNA dysregulation, Front. Cell. Neurosci, vol.9, 2015.

S. J. Broyd, H. H. Van-hell, C. Beale, M. Yücel, and N. Solowij, Acute and chronic effects of cannabinoids on human Cognition-A systematic review, Biol. Psychiatry, vol.79, p.567, 2016.

E. Bubl, E. Kern, D. Ebert, M. Bach, and L. Tebartz-van-elst, Seeing gray when feeling blue? Depression can be measured in the eye of the diseased, Biol. Psychiatry, vol.68, 2010.

E. Bubl, D. Ebert, E. Kern, L. T. Van-elst, and M. Bach, Effect of antidepressive therapy on retinal contrast processing in depressive disorder, Br. J. Psychiatry J. Ment. Sci, vol.201, p.158, 2012.

E. Bubl, M. Dörr, A. Philipsen, D. Ebert, M. Bach et al., Retinal contrast transfer functions in adults with and without ADHD, PLoS One, vol.8, 2013.

E. Bubl, E. Kern, D. Ebert, A. Riedel, L. Tebartz-van-elst et al., Retinal dysfunction of contrast processing in major depression also apparent in cortical activity, Eur. Arch. Psychiatry Clin. Neurosci, 2015.

R. R. Buggage, C. C. Chan, and R. B. Nussenblatt, Ocular manifestations of central nervous system lymphoma, Curr. Opin. Oncol, vol.13, p.142, 2001.

R. N. Caballero-florán, I. Conde-rojas, A. Oviedo-chávez, H. Cortes-calleja, L. F. Lopez-santiago et al., Cannabinoid-induced depression of synaptic transmission is switched to stimulation when dopaminergic tone is increased in the globus pallidus of the rodent, Neuropharmacology, vol.110, p.418, 2016.

G. G. Celesia, D. Kaufman, and S. B. Cone, Simultaneous recording of pattern electroretinography and visual evoked potentials in multiple sclerosis. A method to separate demyelination from axonal damage to the optic nerve, Arch. Neurol, vol.43, p.1252, 1986.

J. Chen, I. Matias, T. Dinh, T. Lu, S. Venezia et al., Finding of endocannabinoids in human eye tissues: implications for glaucoma, Biochem. Biophys. Res. Commun, vol.330, p.1067, 2005.

C. Y. Cheung, .. Ong, Y. Ikram, M. K. Chen, C. Wong et al., Retinal microvasculature in Alzheimer s disease, J. Alzheimers Dis. JAD, vol.42, issue.4, 2014.

C. Y. Cheung, C. Chen, and T. Y. Wong, Ocular fundus photography as a tool to study stroke and dementia, Semin. Neurol, vol.35, p.490, 2015.

C. Y. Cheung, .. Ikram, M. K. Chen, C. Wong, and T. Y. , Imaging retina to study dementia and stroke, Prog. Retin. Eye Res, vol.57, p.107, 2017.

P. A. Constable, M. Bach, L. J. Frishman, B. G. Jeffrey, and A. G. Robson, International Society for Clinical Electrophysiology of Vision, 2017. ISCEV Standard for clinical electro-oculography (2017 update), Doc. Ophthalmol. Adv. Ophthalmol, vol.134

A. Cronin-golomb, J. F. Rizzo, S. Corkin, and J. H. Growdon, Visual function in Alzheimer s disease and normal aginga, Ann. N. Y. Acad. Sci, vol.640, p.35, 1991.

R. W. Crow, L. B. Levin, L. Labree, R. Rubin, and S. E. Feldon, Sweep visual evoked potential evaluation of contrast sensitivity in Alzheimer s dementia, Invest. Ophthalmol. Vis. Sci, vol.44, p.878, 2003.

S. Davanger, O. P. Ottersen, and J. Storm-mathisen, Glutamate, GABA, and glycine in the human retina: an immunocytochemical investigation, J. Comp. Neurol, vol.311, p.494, 1991.

C. F. De-souza, M. L. Acosta, P. J. Polkinghorne, C. N. Mcghee, and M. Kalloniatis, Amino acid immunoreactivity in normal human retina and after brachytherapy, Clin. Exp. Optom. J. Aust. Optom. Assoc, vol.96, p.507, 2013.

L. Degenhardt, W. Chiu, N. Sampson, R. C. Kessler, J. C. Anthony et al., Toward a global view of alcohol, tobacco, cannabis, and cocaine use:`ndings from the WHO World Mental Health Surveys, PLoS Med, vol.5, 2008.

J. E. Dowling and B. Ehinger, The interplexiform cell system. I. Synapses of the dopaminergic neurons of the gold`sh retina, Proc. R. Soc. Lond. Ser. B Contain. Pap. Biol. Charact. R. Soc. G. B, vol.201, p.26, 1978.

A. A. El-shazly, -. Farweez, Y. A. Elzankalony, Y. A. Elewa, L. S. Farweez et al., Ebect of smoking on MACULAR function and structure in active smokers versus passive smokers, Retina Phila. Pa, vol.38, 2018.

J. Fam, A. J. Rush, B. Haaland, S. Barbier, and C. Luu, Visual contrast sensitivity in major depressive disorder, J. Psychosom. Res, vol.75, p.86, 2013.

E. V. Famiglietti and H. Kolb, Structural basis for ON-and OFF-center responses in retinal ganglion cells, Science, vol.194, p.195, 1976.

S. Fan and S. Yazulla, Biphasic modulation of voltage-dependent currents of retinal cones by cannabinoid CB1 receptor agonist WIN 55212-2, Vis. Neurosci, vol.20, p.188, 2003.

S. Fan and S. Yazulla, Inhibitory interaction of cannabinoid CB1 receptor and dopamine D2 receptor agonists on voltage-gated currents of gold, vol.69, p.77, 2004.

S. Fan and S. Yazulla, Reciprocal inhibition of voltage-gated potassium currents (I K(V)) by activation of cannabinoid CB1 and dopamine D1 receptors in ON bipolar cells of gold`sh retina, Vis. Neurosci, vol.22, p.63, 2005.

S. Fan and S. Yazulla, Retrograde endocannabinoid inhibition of gold`sh retinal cones is mediated by 2-arachidonoyl glycerol, Vis. Neurosci, vol.24, p.267, 2007.

C. Faure, T. Schwitzer, C. Hansen, and S. Randhawa, Diagnostic and therapeutic challenges. Retina Phila, 2016.

M. Fornaro, F. Bandini, C. Ogliastro, C. Cordano, M. Martino et al., Electroretinographic assessment in major depressed patients receiving duloxetine: might differences between responders and non-responders indicate a differential biological background, J. Affect. Disord, vol.135, p.159, 2011.

M. Fornaro, F. Bandini, L. Cestari, C. Cordano, C. Ogliastro et al., Electroretinographic modi`cations induced by agomelatine: a novel avenue to the understanding of the claimed antidepressant effect of the drug?, Neuropsychiatr. J. Sleep Disord. Treat. Care, vol.10, p.914, 2014.

K. N. Fountoulakis, F. Fotiou, A. Iacovides, and G. Kaprinis, Is there a dysfunction in the visual system of depressed patients, Ann. Gen. Psychiatry, vol.4, 2005.

J. M. Frederick, M. E. Rayborn, A. M. Laties, D. M. Lam, and J. G. Holly`eld, Dopaminergic neurons in the human retina, J. Comp. Neurol, vol.210, p.79, 1982.

E. Garcia-martin, D. Rodriguez-mena, M. Satue, C. Almarcegui, I. Dolz et al., Electrophysiology and optical coherence tomography to evaluate Parkinson disease severity, Invest. Ophthalmol. Vis. Sci, vol.55, p.705, 2014.

A. M. Gawienowski, D. Chatterjee, P. J. Anderson, D. L. Epstein, and W. M. Grant, Effect of delta 9-tetrahydrocannabinol on monoamine oxidase activity in bovine eye tissues, in vitro, Invest. Ophthalmol. Vis. Sci, vol.22, p.485, 1982.

J. R. Glausier, D. A. Lewis, I. Gottlob, E. Schneider, W. Heider et al., Alteration of visual evoked potentials and electroretinograms in Parkinson s disease, Electroencephalogr. Clin. Neurophysiol, vol.66, p.357, 1987.

M. Hébert, P. Lachapelle, and M. Dumont, Reproducibility of electroretinograms recorded with DTL electrodes, Doc. Ophthalmol. Adv. Ophthalmol, vol.91, p.342, 1995.

M. Hébert, . Vaegan, and P. Lachapelle, Reproducibility of ERG responses obtained with the DTL electrode, Vision Res, vol.39, p.1070, 1999.

M. Hébert, A. Gagné, M. Paradis, V. Jomphe, M. Roy et al., Retinal response to light in young nonaffected obspring at high genetic risk of neuropsychiatric brain disorders, Biol. Psychiatry, vol.67, p.274, 2010.

M. Hébert, C. Mérette, T. Paccalet, C. Émond, A. Gagné et al., Light evoked potentials measured by electroretinogram may tap into the neurodevelopmental roots of schizophrenia, Schizophr. Res, 2015.

M. Hébert, C. Mérette, T. Paccalet, A. Gagné, and M. Maziade, Electroretinographic anomalies in medicated and drug free patients with major depression: tagging the developmental roots of major psychiatric disorders, Prog. Neuropsychopharmacol. Biol. Psychiatry, vol.75, p.15, 2017.

W. Ho, Y. Leung, A. W. Tsang, .. So, K. Chiu et al., Review: tauopathy in the retina and optic nerve: does it shadow pathological changes in the brain?, Mol. Vis, vol.18, 2012.

G. E. Holder, Pattern electroretinography (PERG) and an integrated approach to visual pathway diagnosis, Prog. Retin. Eye Res, vol.20, p.561, 2001.

G. E. Holder, R. P. Gale, J. F. Acheson, and A. G. Robson, Electrodiagnostic assessment in optic nerve disease, Curr. Opin. Neurol, vol.22, p.10, 2009.

G. E. Holder, G. G. Celesia, Y. Miyake, S. Tobimatsu, and R. G. Weleber, International Federation of Clinical Neurophysiology: recommendations for visual system testing, Clin. Neurophysiol. Ob. J. Int. Fed. Clin. Neurophysiol, vol.121, 2010.

L. E. Hong, M. Tagamets, M. Avila, I. Wonodi, H. Holcomb et al., Speci`c motion processing pathway de`cit during eye tracking in schizophrenia: a performance-matched functional magnetic resonance imaging study, Biol. Psychiatry, vol.57, p.732, 2005.

D. C. Hood, M. Bach, M. Brigell, D. Keating, M. Kondo et al., International Society For Clinical Electrophysiology of Vision, 2012.

T. Schwitzer, Neuroscience and Biobehavioral Reviews xxx, vol.124, p.13, 2018.

M. Hoon, H. Okawa, L. Della-santina, and R. O. Wong, Functional architecture of the retina: development and disease, Prog. Retin. Eye Res, vol.42, pp.44-84, 2014.

T. Huang and C. Lin, Advances in biomarkers of major depressive disorder, Adv. Clin. Chem, vol.68, p.204, 2015.

V. L. Ives-deliperi, F. Howells, D. J. Stein, E. M. Meintjes, and N. Horn, The effects of mindfulness-based cognitive therapy in patients with bipolar disorder: a controlled functional MRI investigation, J. Affect. Disord, vol.150, p.1157, 2013.

K. Januschowski, S. Müller, C. Krupp, M. S. Spitzer, J. Hurst et al., Glutamate and hypoxia as a stress model for the isolated perfused vertebrate retina, J. Vis. Exp. JoVE, 2015.

G. M. Khandaker and R. Dantzer, Is there a role for immune-to-brain communication in schizophrenia, Psychopharmacology (Berl.), vol.233, pp.1559-1573, 2016.

G. M. Khandaker, L. Cousins, J. Deakin, B. R. Lennox, R. Yolken et al., Inaammation and immunity in schizophrenia: implications for pathophysiology and treatment, Lancet Psychiatry, vol.2, issue.14, pp.122-131, 2015.

D. J. Kim and S. A. Thayer, Activation of CB1 cannabinoid receptors inhibits neurotransmitter release from identi`ed synaptic sites in rat hippocampal cultures, Brain Res, vol.852, p.405, 2000.

H. K. Kim, P. V. Nunes, K. C. Oliveira, L. T. Young, and B. Lafer, Neuropathological relationship between major depression and dementia: a hypothetical model and review, Prog. Neuropsychopharmacol. Biol. Psychiatry, vol.67, p.57, 2016.

M. Koronyo-hamaoui, Y. Koronyo, A. V. Ljubimov, C. A. Miller, M. K. Ko et al., Identi`cation of amyloid plaques in retinas from Alzheimer s patients and noninvasive in vivo optical imaging of retinal plaques in a mouse model, NeuroImage, vol.54, issue.1, pp.204-217, 2011.

P. Koulen, Clustering of neurotransmitter receptors in the mammalian retina, J. Membr. Biol, vol.171, p.105, 1999.

K. Krasodomska, W. Lubi?ski, A. Potemkowski, and K. Honczarenko, Pattern electroretinogram (PERG) and pattern visual evoked potential (PVEP) in the early stages of Alzheimer s disease, Doc. Ophthalmol. Adv. Ophthalmol, vol.121, p.121, 2010.

L. Morgia, C. Ross-cisneros, F. N. Koronyo, Y. Hannibal, J. Gallassi et al., Melanopsin retinal ganglion cell loss in Alzheimer disease, Ann. Neurol, vol.79, p.109, 2016.

M. R. Lalonde, C. A. Jollimore, K. Stevens, S. Barnes, and M. E. Kelly, Cannabinoid receptor-mediated inhibition of calcium signaling in rat retinal ganglion cells, Mol. Vis, vol.12, p.1166, 2006.

T. Langheinrich, L. Tebartz-van-elst, W. A. Lagrèze, M. Bach, C. H. Lücking et al., Visual contrast response functions in Parkinson s disease: evidence from electroretinograms, visually evoked potentials and psychophysics, Clin. Neurophysiol. Ob. J. Int. Fed. Clin. Neurophysiol, vol.111, p.74, 2000.

V. Laprevote, T. Schwitzer, A. Giersch, and R. Schwan, Flash electroretinogram and addictive disorders, Prog. Neuropsychopharmacol. Biol. Psychiatry, vol.56, 2015.

J. Lavoie, P. Illiano, T. D. Sotnikova, R. R. Gainetdinov, J. Beaulieu et al., The electroretinogram as a biomarker of central dopamine and serotonin: potential relevance to psychiatric disorders, Biol. Psychiatry, vol.75, p.486, 2014.

J. Lavoie, P. Illiano, T. D. Sotnikova, R. R. Gainetdinov, J. Beaulieu et al., The electroretinogram as a biomarker of central dopamine and serotonin: potential relevance to psychiatric disorders, Biol. Psychiatry, vol.75, p.486, 2014.

J. Lavoie, M. Maziade, and M. Hébert, The brain through the retina: the aash electroretinogram as a tool to investigate psychiatric disorders. Prog. Neuropsychopharmacol, Biol. Psychiatry, vol.48, p.134, 2014.

J. Lavoie, M. Maziade, and M. Hébert, The brain through the retina: the aash electroretinogram as a tool to investigate psychiatric disorders. Prog. Neuropsychopharmacol, Biol. Psychiatry, vol.48, p.134, 2014.

J. Lavoie, M. Hébert, and J. Beaulieu, Looking beyond the role of glycogen synthase kinase-3 genetic expression on electroretinogram response: what about lithium?, Biol. Psychiatry, vol.77, pp.15-17, 2015.

M. Leboyer, J. Oliveira, R. Tamouza, and L. Groc, Is it time for immunopsychiatry in psychotic disorders, Psychopharmacology (Berl.), vol.233, 2016.

A. London, I. Benhar, and M. Schwartz, The retina as a window to the brain-from eye research to CNS disorders, Nat. Rev. Neurol, vol.9, p.53, 2013.

A. L. Lopresti, G. L. Maker, S. D. Hood, and P. D. Drummond, A review of peripheral biomarkers in major depression: the potential of inaammatory and oxidative stress biomarkers, Prog. Neuropsychopharmacol. Biol. Psychiatry, vol.48, p.111, 2014.

Y. Lu, Z. Li, X. Zhang, B. Ming, J. Jia et al., Retinal nerve`ber layer structure abnormalities in early Alzheimer s disease: evidence in optical coherence tomography, Neurosci. Lett, vol.480, 2010.

A. Lucas, A. Thirion, R. Schwan, J. Krieg, K. Angioi-duprez et al., Association between increased retinal background noise and co-occurrent regular cannabis and alcohol use, Prog. Neuropsychopharmacol. Biol. Psychiatry, vol.89, p.340, 2018.
URL : https://hal.archives-ouvertes.fr/hal-01932214

P. D. Lukasiewicz and C. R. Shields, A diversity of GABA receptors in the retina, Semin. Cell Dev. Biol, vol.9, p.299, 1998.

R. E. Marc, R. F. Murry, and S. F. Basinger, Pattern recognition of amino acid signatures in retinal neurons, J. Neurosci. Ob. J. Soc. Neurosci, vol.15, p.5129, 1995.

M. F. Marmor, P. Hock, G. Schechter, A. Pfefferbaum, P. A. Berger et al., Oscillatory potentials as a marker for dopaminergic disease, Doc. Ophthalmol. Adv. Ophthalmol, vol.69, p.261, 1988.

M. F. Marmor, P. Hock, G. Schechter, A. Pfefferbaum, P. A. Berger et al., Oscillatory potentials as a marker for dopaminergic disease, Doc. Ophthalmol. Adv. Ophthalmol, vol.69, p.261, 1988.

M. F. Marmor, M. G. Brigell, D. L. Mcculloch, C. A. Westall, and M. Bach, International Society for Clinical Electrophysiology of Vision, Doc. Ophthalmol. Adv. Ophthalmol, vol.122, 2011.

D. W. Marshak, Synaptic inputs to dopaminergic neurons in mammalian retinas, Prog. Brain Res, vol.131, p.91, 2001.

I. Matias, J. W. Wang, A. S. Moriello, A. Nieves, D. F. Woodward et al., Changes in endocannabinoid and palmitoylethanolamide levels in eye tissues of patients with diabetic retinopathy and age-related macular degeneration, Prostaglandins Leukot. Essent. Fatty Acids, vol.75, p.418, 2006.

D. L. Mcculloch, M. F. Marmor, M. G. Brigell, R. Hamilton, G. E. Holder et al., ISCEV Standard for full-`eld clinical electroretinography (2015 update), Doc. Ophthalmol. Adv. Ophthalmol, vol.130, p.12, 2015.

R. Mechoulam and L. Hanus, A historical overview of chemical research on cannabinoids, Chem. Phys. Lipids, vol.108, p.13, 2000.

R. Mechoulam and L. A. Parker, The endocannabinoid system and the brain, Annu. Rev. Psychol, vol.64, p.47, 2013.

R. Mechoulam, M. Peters, E. Murillo-rodriguez, and L. O. Hanus, Cannabidiol--recent advances, Chem. Biodivers, vol.4, 2007.

M. H. Meier, A. Caspi, A. Ambler, H. Harrington, R. Houts et al., Persistent cannabis users show neuropsychological decline from childhood to midlife, Proc. Natl. Acad. Sci. 109, E2657 E2664, 2012.

T. P. Middleton and D. A. Protti, Cannabinoids modulate spontaneous synaptic activity in retinal ganglion cells, Vis. Neurosci, vol.28, p.402, 2011.

J. J. Miguel-hidalgo, Molecular neuropathology of astrocytes and oligodendrocytes in alcohol use disorders, Front. Mol. Neurosci, vol.11, 2018.

M. M. Moschos, I. Markopoulos, I. Chatziralli, A. Rouvas, S. G. Papageorgiou et al., Structural and functional impairment of the retina and optic nerve in Alzheimer s disease, Curr. Alzheimer Res, vol.9, p.788, 2012.

J. Nguyen-legros, A. Simon, I. Caillé, and B. Bloch, Immunocytochemical localization of dopamine D1 receptors in the retina of mammals, Vis. Neurosci, vol.14, p.551, 1997.

J. V. Odom, M. Bach, M. Brigell, G. E. Holder, D. L. Mcculloch et al., ISCEV standard for clinical visual evoked potentials (2009 update), Doc. Ophthalmol. Adv. Ophthalmol, vol.120, p.119, 2010.

C. A. Opere, W. D. Zheng, M. Zhao, J. S. Lee, K. H. Kulkarni et al., Inhibition of potassium-and ischemia-evoked [3H] D-aspartate release from isolated bovine retina by cannabinoids, Curr. Eye Res, vol.31, p.653, 2006.

A. M. Palmowski-wolfe, M. T. Perez, S. Behnke, G. Fuss, M. Martziniak et al., Inauence of dopamine de`ciency in early Parkinson s disease on the slow stimulation multifocal-ERG, Doc. Ophthalmol. Adv. Ophthalmol, vol.112, p.215, 2006.

V. Parisi, R. Restuccia, F. Fattapposta, C. Mina, M. G. Bucci et al., Morphological and functional retinal impairment in Alzheimer s disease patients, Clin. Neurophysiol. Ob. J. Int. Fed. Clin. Neurophysiol, vol.112, p.1867, 2001.

R. Parthasarathy, K. M. Chow, Z. Derafshi, M. P. Fautsch, J. R. Hetling et al., Reduction of amyloid-beta levels in mouse eye tissues by intra-vitreally delivered neprilysin, Exp. Eye Res, vol.138, p.144, 2015.

O. Pasternak, M. Kubicki, and M. E. Shenton, In vivo imaging of neuroinaammation in schizophrenia, Schizophr. Res, 2015.

N. Patton, T. Aslam, T. Macgillivray, A. Pattie, I. J. Deary et al., Retinal vascular image analysis as a potential screening tool for cerebrovascular disease: a rationale based on homology between cerebral and retinal microvasculatures, J. Anat, vol.206, p.348, 2005.

N. Patton, T. M. Aslam, T. Macgillivray, I. J. Deary, B. Dhillon et al., Retinal image analysis: concepts, applications and potential, Prog. Retin. Eye Res, vol.25, p.127, 2006.

A. Peppe, P. Stanzione, F. Pierelli, D. De-angelis, M. Pierantozzi et al., Visual alterations in de novo Parkinson s disease: pattern electroretinogram latencies are more delayed and more reversible by levodopa than are visual evoked potentials, Neurology, vol.45, p.1148, 1995.

R. G. Pertwee, A. C. Howlett, M. E. Abood, S. P. Alexander, V. Di-marzo et al., , p.11

, Anomalies fonctionnelles rétiniennes dans les troubles neuropsychiatriques et leurs liens avec les dysfonctionnements

T. Schwitzer, Neuroscience and Biobehavioral Reviews xxx, 2018.

R. A. , International union of basic and clinical pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB? and CB?, Pharmacol. Rev, vol.62, p.631, 2010.

E. Popova, Role of dopamine in distal retina, J. Comp. Physiol. A Neuroethol. Sens. Neural. Behav. Physiol, vol.333, p.358, 0200.

E. Popova, Ionotropic GABA receptors and distal retinal ON and OFF responses. Scienti`ca, 2014.

A. Porcella, C. Maxia, G. L. Gessa, and L. Pani, The human eye expresses high levels of CB1 cannabinoid receptor mRNA and protein, Eur. J. Neurosci, vol.12, p.1127, 2000.

N. V. Rangaswamy, L. J. Frishman, E. U. Dorotheo, J. S. Schibman, H. M. Bahrani et al., Photopic ERGs in patients with optic neuropathies: comparison with primate ERGs after pharmacologic blockade of inner retina, Invest. Ophthalmol. Vis. Sci, vol.45, p.3837, 2004.

R. A. Reis, A. L. Ventura, R. C. Kubrusly, M. C. De-mello, and F. G. De-mello, Dopaminergic signaling in the developing retina, Brain Res. Rev, vol.54, p.188, 2007.

D. Robbe, G. Alonso, F. Duchamp, J. Bockaert, and O. J. Manzoni, Localization and mechanisms of action of cannabinoid receptors at the glutamatergic synapses of the mouse nucleus accumbens, J. Neurosci. Ob. J. Soc. Neurosci, vol.21, p.116, 2001.

S. G. Rosolen, F. Rigaudière, J. Legargasson, C. Chalier, M. Ru`ange et al., Comparing the photopic ERG i-wave in different species, Vet. Ophthalmol, vol.7, p.192, 2004.

M. Roy, A. Roy, D. Smelson, S. Brown, and L. Weinberger, Reduced blue cone electroretinogram in withdrawn cocaine dependent patients: a replication, Biol. Psychiatry, vol.42, p.633, 1997.

M. Roy, A. Roy, J. Williams, L. Weinberger, and D. Smelson, Reduced blue cone electroretinogram in cocaine-withdrawn patients, Arch. Gen. Psychiatry, vol.54, p.156, 1997.

A. Roy, M. Roy, J. Berman, and B. Gonzalez, Blue cone electroretinogram amplitudes are related to dopamine function in cocaine-dependent patients, Psychiatry Res, vol.117, p.195, 2003.

G. Sanacora, G. F. Mason, D. L. Rothman, K. L. Behar, F. Hyder et al., Reduced cortical gamma-aminobutyric acid levels in depressed patients determined by proton magnetic resonance spectroscopy, Arch. Gen. Psychiatry, vol.56, 1999.

G. Sanacora, G. F. Mason, D. L. Rothman, F. Hyder, J. J. Ciarcia et al., Increased cortical GABA concentrations in depressed patients receiving ECT, Am. J. Psychiatry, vol.160, p.579, 2003.

E. Schlicker, J. Timm, and M. Göthert, Cannabinoid receptor-mediated inhibition of dopamine release in the retina, Naunyn Schmiedebergs Arch. Pharmacol, vol.354, p.795, 1996.

T. Schwitzer, J. Lavoie, A. Giersch, R. Schwan, and V. Laprevote, The emerging eld of retinal electrophysiological measurements in psychiatric research: a review of the`ndings and the perspectives in major depressive disorder, J. Psychiatr. Res, vol.70, 2015.

T. Schwitzer, R. Schwan, K. Angioi-duprez, I. Ingster-moati, L. Lalanne et al., The cannabinoid system and visual processing: a review on experimental`ndings and clinical presumptions, Eur. Neuropsychopharmacol. J. Eur. Coll. Neuropsychopharmacol, vol.25, p.112, 2015.

T. Schwitzer, M. P. Robert, A. Giersch, K. Angioi-duprez, I. Ingster-moati et al., Transient retinal dysfunctions after acute cannabis use, Eur. Addict. Res, vol.22, p.291, 2016.

T. Schwitzer, R. Schwan, K. Angioi-duprez, A. Giersch, and V. Laprevote, The endocannabinoid system in the retina: from physiology to practical and therapeutic applications, Neural Plast, 2016.

T. Schwitzer, R. Schwan, F. Bernardin, C. Jeantet, K. Angioi-duprez et al., Commentary: anatomical constitution of sense organs as a marker of mental disorders, Front. Behav. Neurosci, vol.10, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01586834

T. Schwitzer, R. Schwan, E. Albuisson, A. Giersch, L. Lalanne et al., Association between regular Cannabis use and ganglion cell dysfunction, JAMA Ophthalmol, vol.135, p.60, 2017.

T. Schwitzer, R. Schwan, E. Bubl, L. Lalanne, K. Angioi-duprez et al., Looking into the brain through the retinal ganglion cells in psychiatric disorders: a review of evidences, Prog. Neuropsychopharmacol. Biol, 2017.

T. Schwitzer, R. Schwan, K. Angioi-duprez, A. Giersch, L. Lalanne et al., Delayed bipolar and ganglion cells neuroretinal processing in regular cannabis users: the retina as a relevant site to investigate brain synaptic transmission dysfunctions, J. Psychiatr. Res, vol.103, p.82, 2018.

J. Seggie, H. Macmillan, L. Grif`th, H. S. Shannon, J. Martin et al., Retinal pigment epithelium response and the use of the EOG and Arden Ratio in depression, Psychiatry Res, vol.36, p.185, 1991.

R. C. Sergott, E. Frohman, R. Glanzman, A. Al-sabbagh, J. W. Shum et al., The role of optical coherence tomography in multiple sclerosis: expert panel consensus, Neural Regen. Res, vol.263, p.36, 2007.

S. M. Silverstein and R. Rosen, Schizophrenia and the eye, Schizophr. Res. Cogn, vol.2, p.55, 2015.

W. D. Stamer, S. F. Golightly, Y. Hosohata, E. P. Ryan, A. C. Porter et al., Cannabinoid CB(1) receptor expression, activation and detection of endogenous ligand in trabecular meshwork and ciliary process tissues, Eur. J. Pharmacol, vol.431, p.286, 2001.

A. Straiker and J. M. Sullivan, Cannabinoid receptor activation differentially modulates ion channels in photoreceptors of the tiger salamander, J. Neurophysiol, vol.89, 2003.

A. Straiker, N. Stella, D. Piomelli, K. Mackie, H. J. Karten et al., Cannabinoid CB1 receptors and ligands in vertebrate retina: localization and function of an endogenous signaling system, Proc. Natl. Acad. Sci. U. S. A, vol.96, p.14570, 1999.

A. J. Straiker, G. Maguire, K. Mackie, and J. Lindsey, Localization of cannabinoid CB1 receptors in the human anterior eye and retina, Invest. Ophthalmol. Vis. Sci, vol.40, p.2448, 1999.

M. J. Stuart, G. Singhal, and B. T. Baune, Systematic review of the neurobiological relevance of chemokines to psychiatric disorders, Front. Cell. Neurosci, vol.9, 2015.

B. Szabo, L. Dörner, C. Pfreundtner, W. Nörenberg, and K. Starke, Inhibition of GABAergic inhibitory postsynaptic currents by cannabinoids in rat corpus striatum, Neuroscience, vol.85, p.403, 1998.

B. Szabo, S. Siemes, and I. Wallmichrath, Inhibition of GABAergic neurotransmission in the ventral tegmental area by cannabinoids, Eur. J. Neurosci, vol.15, 2002.

S. B. Varghese, J. C. Reid, E. E. Hartmann, and K. T. Keyser, The effects of nicotine on the human electroretinogram, Invest. Ophthalmol. Vis. Sci, vol.52, p.9451, 2011.

N. D. Volkow, R. D. Baler, W. M. Compton, and S. R. Weiss, Adverse health effects of marijuana use, N. Engl. J. Med, vol.370, 2014.

L. Wachtmeister, Oscillatory potentials in the retina: what do they reveal, Prog. Retin. Eye Res, vol.17, p.521, 1998.

J. Wang, Y. Wu, S. Heegaard, and M. Kolko, Cyclooxygenase-2 expression in the normal human eye and its expression pattern in selected eye tumours, Acta Ophthalmol. (Copenh.), vol.89, p.685, 2011.

A. Warrier and M. Wilson, Endocannabinoid signaling regulates spontaneous transmitter release from embryonic retinal amacrine cells, Vis. Neurosci, vol.24, p.35, 2007.

B. Weber and E. Schlicker, Modulation of dopamine release in the guinea-pig retina by G(i)-but not by G(s)-or G(q)-protein-coupled receptors, Fundam. Clin. Pharmacol, vol.15, p.400, 2001.

Y. Wei, X. Wang, and L. Wang, Presence and regulation of cannabinoid receptors in human retinal pigment epithelial cells, Mol. Vis, vol.15, p.1251, 2009.

P. Witkovsky, Dopamine and retinal function, Doc. Ophthalmol. Adv. Ophthalmol, vol.108, p.40, 2004.

X. Wu and E. D. French, Effects of chronic delta9-tetrahydrocannabinol on rat midbrain dopamine neurons: an electrophysiological assessment, Neuropharmacology, vol.39, p.398, 2000.

S. M. Wu and B. R. Maple, Amino acid neurotransmitters in the retina: a functional overview, Vision Res, vol.38, p.1384, 1998.

T. Yamasaki, S. Horie, Y. Ohyagi, E. Tanaka, N. Nakamura et al., A potential VEP biomarker for mild cognitive impairment: evidence from selective visual de`cit of higher-level dorsal pathway, J. Alzheimers Dis. JAD, vol.53, p.676, 2016.

S. Yazulla, Endocannabinoids in the retina: from marijuana to neuroprotection, Prog. Retin. Eye Res, vol.27, p.526, 2008.

S. Yazulla, Endocannabinoids in the retina: from marijuana to neuroprotection, Prog. Retin. Eye Res, vol.27, p.526, 2008.

S. Yazulla, K. M. Studholme, H. H. Mcintosh, and S. F. Fan, Cannabinoid receptors on gold`sh retinal bipolar cells: electron-microscope immunocytochemistry and whole-cell recordings, Vis. Neurosci, vol.17, p.401, 2000.

A. Yoonessi and A. Yoonessi, Functional assessment of magno, parvo and konio-cellular pathways; current state and future clinical applications, J. Ophthalmic Vis. Res, vol.6, p.126, 2011.

C. Zhang, H. Wu, S. Wang, S. Yin, X. Lu et al., Suppression of outward K + currents by WIN55212-2 in rat retinal ganglion cells is independent of CB1/CB2 receptors, Neuroscience, vol.253, p.193, 2013.

D. Zobor, T. Strasser, G. Zobor, F. Schober, A. Messias et al., Ophthalmological assessment of cannabis-induced persisting perception disorder: is there a direct retinal effect?, Doc. Ophthalmol. Adv. Ophthalmol, vol.130, p.130, 2015.